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Abstract 
The objectives of this project were to research and explain the fundamentals of the stock 
market and to practice the skills necessary to make successful trades within the market. A 
four member team investigated the creation of the modern stock market, the  histories of 
NYSE and NASDAQ, and the political factors that affect the stock market. Members also 
performed an eight-week stock market simulation, each specializing in a particular 
trading strategy and sector of the market. One member used fundamental analysis 
investing with a diverse portfolio; another used company history and projected growth to 
invest in the life sciences, the third member used historical analysis to invest in the 
gaming industry, and the last member used the income and growth strategies to invest 
specifically in shoe manufacturing and technology companies.  Only the portfolio that 
focused upon the gaming industry produced a profit, while the other portfolios lost 
money. The results indicated that (a) companies that respond to customer feedback tend 
to succeed; (b) the gaming industry is running at full steam and that now is a good time to 
invest; (c) basing your trading decisions on the quality of a product or service is only 
useful in some sectors, like technology, while it is less useful in other sectors, like 
banking; and (d) finally, it was concluded that investing in the life sciences is a risky 
venture, because developing technology is kept far from the investors’ evaluation and 
loss of FDA approval can cause unpredictable and devastating losses in stock value. 
 
 
 
2 
 
Acknowledgements 
We would like to thank Professor Dalin Tang for his tireless guidance and the 
advice he has given.  In addition, Investopedia deserves thanks for providing the great 
simulator we used to trade our stocks and manage our portfolios. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
Table of Contents 
Abstract ........................................................................................................................................... 1 
Acknowledgements ......................................................................................................................... 2 
List of Figures ................................................................................................................................. 5 
List of Tables ................................................................................................................................... 6 
Chapter 1: Introduction ................................................................................................................. 10 
1.1 Goals .................................................................................................................................... 10 
1.2 Project Overview ................................................................................................................. 12 
Chapter 2: Stock Market Overview ............................................................................................... 13 
2.1 The Creation of the Modern Stock Market .......................................................................... 13 
2.2 History of NYSE ................................................................................................................. 14 
2.3 History of NASDAQ ........................................................................................................... 15 
2.4 Political Factors Affecting the Stock Market ...................................................................... 16 
Chapter 3:  Online Stock Market Simulators................................................................................. 19 
Chapter 4: Diversified Portfolio Utilizing Fundamental Analysis ................................................ 21 
4.1 Strategies employed............................................................................................................. 21 
4.2 Companies Chosen and Reasons ......................................................................................... 21 
4.3 Weekly Simulation Reports ................................................................................................. 25 
Chapter 5: Investing in the Life Sciences using Company History and Projected Growth ........... 37 
5.1 Companies Chosen and Reasons ......................................................................................... 37 
4 
 
5.2 Weekly Simulation Report .................................................................................................. 45 
Chapter 6: Video Game Industry Stocks with Historically Strong Market Performance .............. 57 
6.1 Strategies Employed ............................................................................................................ 57 
6.2 Companies Chosen and Reasons ......................................................................................... 57 
6.3 Weekly Simulation Report .................................................................................................. 68 
Chapter 7: Investing in Technology and Shoe Manufacturing Sectors using the Income and 
Growth Strategies .......................................................................................................................... 78 
7.1 Strategies employed............................................................................................................. 78 
7.2 Companies Chosen and Reasons ......................................................................................... 80 
7.3 Weekly Simulation Reports ................................................................................................. 88 
Chapter 8: Comparison of Cumulative Results and Discussion .................................................. 100 
8.1 Diversified Portfolio Utilizing Fundamental Analysis ...................................................... 100 
8.2 Investing in the Life Sciences using Company History and Projected Growth ................. 103 
8.3 Video Game Industry Stocks with Historically Strong Market Performance ................... 103 
8.4 Investing in Technology and Shoe Manufacturing Sectors using the Income and Growth 
Strategies ................................................................................................................................. 110 
Chapter 9: Conclusion ................................................................................................................. 112 
References: .................................................................................................................................. 114 
Appendix ..................................................................................................................................... 118 
List of Stock Exchanges around the World ............................................................................. 118 
 
5 
 
List of Figures 
Figure 4.1. BAC Stock Chart for Week of Sept. 29 - Oct 2, 2009 ------------------- 28  
Figure 4.2. SEIC Stock Chart for Week of Nov. 2 – Nov. 6, 2009 ------------------ 34 
Figure 5.1: Stock prices in US dollars over time in months from  
                  May 2008 to March 2008 ------------------------------------- -------------- 39 
Figure 5.2: Stock performance of Illumina --------------------------------------------- 44 
Figure 7.1: Monthly performance of Google (SEP-OCT) ---------------------------- 94 
Figure 7.2: Monthly performance of APPLE (SEP-OCT) ---------------------------- 94 
Figure 7.3: Monthly performance of Nvidia (SEP-OCT) ----------------------------- 95 
Figure 7.4: Monthly performance of Sprint (SEP-OCT) ------------------------------ 95 
 
 
 
 
 
 
 
 
 
6 
 
List of Tables 
Table 4.1. Transaction History -------------------------------------------------------------- 25 
Table 4.2. Portfolio Value to Date ---------------------------------------------------------- 27 
Table 4.3. Week End Portfolio -------------------------------------------------------------- 29 
Table 4.4. Trades made during simulation week 3 --------------------------------------- 29 
Table 4.5. Trades for the Week of Oct. 26, 2009------------------------------------------ 31 
Table 4.6. Week End Portfolio -------------------------------------------------------------- 31 
Table 4.7. Week End Portfolio -------------------------------------------------------------- 33 
Table 4.8. Trades for the Week of Nov. 2, 2009 ------------------------------------------ 34 
Table 4.9. Trades for the Week of Nov. 9, 2009 ------------------------------------------ 35 
Table 5.1: Stock Information: Gilead ------------------------------------------------------- 38 
Table 5.2: Stock Information: Genzyme --------------------------------------------------- 41 
Table 5.3: Stock Information: Celgene ----------------------------------------------------- 43 
Table 5.4: Stock Information: Illumina ----------------------------------------------------- 45 
Table 5.5: Initial Purchases ------------------------------------------------------------------- 45 
Table 5.6: Purchasing Stock in Swine Flu Vaccine Manufacturers --------------------- 47 
Table 5.7: Transactions made on 09/28/2009----------------------------------------------- 48 
7 
 
Table 5.8: Transactions made on 10/30/2009 ------------------------------------------------ 51 
Table 6.1: Stock Information: Activision-Blizzard ----------------------------------------- 58 
Table 6.2: Stock Information: Konami ------------------------------------------------------- 60 
Table 6.3: Stock Information: Take-Two ---------------------------------------------------- 61 
Table 6.4: Stock Information: Electronic Arts ----------------------------------------------- 62 
Table 6.5: Stock Information: Nintendo CO LTD ------------------------------------------- 64 
Table 6.6: Stock Information: Microsoft Corporation -------------------------------------- 66 
Table 6.7: Stock Information: PepsiCo Inc -------------------------------------------------- 68 
Table 6.8: Day 1 Transaction Record --------------------------------------------------------- 69 
Table 6.9: Day 2 Transaction Record --------------------------------------------------------- 70 
Table 6.10: Day 3 Transaction Record ------------------------------------------------------- 70 
Table 6.11: Day 4 Transaction Record ------------------------------------------------------- 71 
Table 6.12: Day 8 Transaction Record ------------------------------------------------------- 72 
Table 6.13: Day 17 Transaction Record ------------------------------------------------------ 74 
Table 6.14: Day 19 Transaction Record ------------------------------------------------------ 74 
Table 6.15: Day 27 Transaction Record ------------------------------------------------------ 75 
Table 6.16: Day 28 Transaction Record ------------------------------------------------------ 75 
8 
 
Table 6.17: Day 35 Transaction Record ------------------------------------------------------- 77 
Table 6.18: Week 8 Transaction Record ------------------------------------------------------- 77 
Table 7.1: Criteria of Growth Investing Strategy --------------------------------------------- 80 
Table 7.2: Stock Information – Nokia ---------------------------------------------------------- 81 
Table 7.3: Stock Information – Apple ---------------------------------------------------------- 82 
Table 7.4: Stock Information – HP ------------------------------------------------------------- 83 
Table 7.5: Stock Information – Dell ------------------------------------------------------------ 84 
Table 7.6: Stock Information – Google -------------------------------------------------------- 85 
Table 7.7: Stock Information – Yahoo --------------------------------------------------------- 86 
Table 7.8: Stock Information – Nike ----------------------------------------------------------- 87 
Table 7.9: Stock Information – Amazon ------------------------------------------------------ 88 
Table 7.10: Stock Trading Summary (09/21/2009) ------------------------------------------ 89 
Table 7.11: Stock Trading Summary (09/24/2009) ------------------------------------------ 90 
Table 7.12: Stock Trading Summary (09/30/2009) ------------------------------------------ 91 
Table 7.13: Stock Trading Summary (10/02/2009) ------------------------------------------ 91 
Table 7.14: Stock Trading Summary (10/07/2009) ------------------------------------------ 92 
Table 7.15: Stock Trading Summary (10/08/2009) ------------------------------------------ 93 
9 
 
Table 7.16: Stock Trading Summary (10/09/2009) ----------------------------------------- 93 
Table 7.17: Stock Trading Summary (10/30/2009) ----------------------------------------- 97 
Table 7.18: Stock Trading Summary (11/02/2009) ----------------------------------------- 98 
Table 7.19: Stock Trading Summary (11/09/2009) ----------------------------------------- 99 
 
 
 
 
 
 
 
 
 
 
  
10 
 
Chapter 1: Introduction  
           For our IQP, our four member group is attempting to understand the US stock 
market and the various trading strategies by undergoing an eight week investing 
simulation. By using real-time data provided by Investopedia.com, we used an allocation 
of hypothetical funds to invest in at least eight companies. Over the course of the 
simulation, we sought to learn as much as we can about the market and what affects it 
without actually investing any of our own money. A set of goals was established before 
the start of the simulation to remind us of what needed to be accomplished and learnt 
during the simulation period. 
1.1 Goals 
We have set nine general goals for this project, which we can group into three 
overall sections.  First, we wish to understand the current economic climate and how the 
economy works, especially by trying to understand and discover the deciding economic 
and political factors governing the stock market.  We will be watching our portfolios as 
they rise and fall, and by analyzing the data at the end of the simulation and comparing it 
to real world events, we will attempt to figure out what factors were responsible for the 
losses and gains we experienced.  In addition, we wish to identify investment bias caused 
by conflict of interests between parties.  By combining what we’ve learned from our 
analysis, as well as independent research gathered during the simulation, we hope to 
better understand how the market works so that we can become wiser investors. 
Second, we wish to develop the skills and knowledge required to do make 
informed market investments.  This includes critical thinking, decision-making, 
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cooperation and communication between team members, independent research, and 
saving and investment strategies.  Members will research different market concepts and 
investing strategies, which will be used to guide them in managing their portfolios.  We 
will be trying to get better at tracking and evaluate the performance of a selected group of 
stocks by using different investing strategies which have been researched beforehand. 
During this time and while doing research, we hope to be able to find trustworthy sources 
that provide reliable information to allow us to make the correct decisions in the stock 
market.  This way we can get a good idea of what to invest in and when to invest by 
analyzing data and information on various companies.  With this practice, we hope to 
become better investors. 
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1.2 Project Overview 
           As previously stated, the heart of this project is an eight week investing simulation 
using false money and real-time data. Members will use the Investopedia.com simulator 
to buy and sell selected stocks that are listed on the NYSE and NASDAQ.  Available 
stocks include the companies listed on both Dow Jones Industrial Average and the 
S&P500 index. 
            Members will provide a detailed analysis as to why they expect the stocks they 
select to succeed.  During the simulation, new companies in which to invest may be 
selected, and more analysis must be provided justifying the change.  Each member will 
be required to keep a day-to-day journal recording the loss and gains during the 
simulation.  This journal will also be a record of trades, and the motivations behind them.  
Redundant records will be kept as excel spreadsheets to prevent data loss and ensure 
accuracy. 
Additionally, each group member will research and analyze a distinct topic related 
to the history of the stock market and the simulation program.  Written accounts of this 
research will be included in the final report.  We believe this project will run smoothly. 
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Chapter 2: Stock Market Overview 
2.1 The Creation of the Modern Stock Market 
 One of the first instances of a stock market like financial system evolved in 12th 
century France.  The Courratiers de Change were responsible for managing agricultural 
debts on behalf of banks.  These Courratiers are often considered the first brokers as they 
traded in debts.  In the following century in the year 1309 AD, a group of commodity 
traders, known as the Brugse Beurse, met in a building owned by Van der Beurze , for 
whom the group is named, in Antwerp to trade.  This form of commodity trading became 
popular and subsequently spread to Flanders, Ghent, and Amsterdam. 
 Later in the middle of the 13th century, Venetian bankers elected to begin trading 
government securities.  This practice was later regulated in 1351 when the Venetian 
government outlawed spreading malicious rumors whose intent was to devalue 
government funds.  This practice of trading in government securities was later practiced 
in many of the neighboring city-states of Pisa, Verona, Genoa, and Florence starting in 
the 14th century. 
 Centuries later, the Dutch founded the first stock exchange in the Netherlands in 
Amersterdam.  In 1602, the Dutch East India Company, a joint stock company, sold its 
first shares through the Amsterdam Stock Exchange.  As a joint stock company, the East 
India Company allowed shareholders to invest in business ventures.  Their investments 
entitled them to both the possible profits and losses of the enterprises.  The Amsterdam 
Stock Exchange, also known as the Amsterdam Beurs after the famous 13th century 
commodity traders, is recognized as the first financial institution to pioneer the concept of 
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continuous stock trading in the 17th century.  The Dutch are also credited with creating 
the concepts of short selling, debt-equity swaps, option trading, merchant banking, and 
unit trusts.  Imitating the Dutch, the English established a stock exchange in London in 
1688.  The London Stock Exchange was created as a collection of joint stock companies 
similar to the Dutch Easy India Company out of a necessity to find funding for overseas 
voyages.  
Today there are numerous stock exchanges all over the world.  A list of the 
currently operating stock markets can be found in Appendix.  
2.2 History of NYSE 
 The US investment market was born in 1790 when the federal government 
refinanced all federal and state Revolutionary War debt by issuing $80 million in bonds.  
These bonds then became the first major issue of publicly traded securities in the United 
States.  The first trade occured in 1792 when five securities were traded.  Three of them 
were government bonds and two were bank stocks.  In 1817, the New York brokers 
established a formal organization, the New York Stock & Exchange Board (NYS&EB), 
which adopted a constitution with rules for the conduct of business.  By 1824, the annual 
trading at the NYS&EB had reached a peak of 380,000.  In 1863, the NYS&EB changed 
its name to its current name, the New York Stock Exchange (NYSE).  The NYSE then 
moved into 10-12 Board Street, which made Wall and Broad Street the center of 
securities trading in the US. 
In recent history, the NYSE experienced its first 100 million-share day in 1982.  Since 
1982, the daily trading volume of the NYSE have gained exponentially and finally 
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reached 1 billion for the first time in 1997.  The current trading hours of the NYSE was 
first established in 1985.  In 2006, the NYSE merged with ArcaEx, which was the largest 
merger among securities exchanges up to that time.  Since then, the NYSE has merged 
with Wombat Financial software, American Stock Exchange, Euronext, SIAC, 
MatchPoint Trading, and Marco Polo Network.  
2.3 History of NASDAQ 
 The National Association of Securities Dealers Automated Quotation (NASDAQ) 
was the world's first electronic stock market.  Unlike the NYSE, the NASDAQ was 
founded much later, in 1971.  The NASDAQ currently has 3,300 company listings.  
Additionally, it is the one of the largest exchanges in the U.S. with about 1.8 billion 
trades per day. However, the NYSE is still considered larger because its market 
capitalization far exceeds that of the NASDAQ.  Even though the NASDAQ trades shares 
in a variety of companies, it is well known for being a high-tech exchange.  It trades 
many new, high growth, and volatile stocks.  The listing fee on the NASDAQ is 
significantly lower than on the NYSE; therefore, smaller companies tend to do listings on 
the NASDAQ.  
 A company must meet strict financial criteria in order to be listed on the 
NASDAQ National Market.  For instance, they must maintain a stock price of at least $1, 
and the total value of outstanding stocks must be at least $1.1 million.  The NASDAQ 
also has smaller markets for companies who are not able to meet the requirements.  
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2.4 Political Factors Affecting the Stock Market 
 One can commonly observe an apparent ripple effect between political factors and 
the stock market.  The market seems to lose value after catastrophes, such as the 9/11 
attacks in 2001, and it seems to gain value after occasions that rally public confidence, 
such as the election of a popular president.  These informal observations have led many 
investors to believe that they can use information regarding events in the political sphere 
to turn a profit in the stock market.  However, according to a recent study published in 
Finance, this is not the case. 
 Believing that one can predict stock returns based on information that is available 
to the public goes against a widely accepted academic theory, the efficient markets 
hypothesis (EMH) theory.  In short, this theory asserts that stock prices are a perfect 
reflection of all known information, and that these prices will instantly change in 
response to new information (Wikipedia).  If this assertion were true, it would be 
impossible for an investor to consistently outperform the market by using information the 
market already knows.  
 Not everyone accepts the efficient markets hypothesis.  For example, some 
researchers report evidence of a “Democratic premium,” a condition in which excess 
stock returns are consistently higher during Democratic presidencies as compared to 
Republican ones (Santa Clara and Valkanov, 2003).  Still others propose that stock 
returns will be higher during the second half of a presidential election cycle (Booth and 
Booth, 2003). 
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 However, according to the aforementioned paper in Finance, “Real-Time 
Forecasting and Political Stock Market Anomalies: Evidence for the United States,” real 
time modeling approaches support the efficient markets hypothesis.  In this study, 
researchers used monthly U.S. data from 1953 to 2003 to analyze the effect of political 
stock market anomalies on the ability to forecast stock returns in real-time.  Their 
analysis was based on the assumption that an investor can only undermine the EMH if he 
or she can exploit political variables that are available in the present.  In the researcher’s 
model scenario,   the investor must weigh, in every month, all available information on 
macroeconomic, financial, and political variables to forecast one-month-ahead excess 
stock returns.  To deal with the information in a systematic manner, the investor applies a 
recursive modeling approach similar to the model developed by Pesaran and 
Timmermann (1995), which implies the use of political variables.  As new datum become 
available, the investor restarts the search.  
Researchers compared two hypothetical investors in this scenario using near 
identical modeling approaches.  The one difference between the two is that Investor A 
assigns weight to political variables, while Investor B ignores such variables.  The two 
modeling approaches are applied over the period of fifty tears, and the outcomes are 
compared for each investor.  
According to the authors of this study, performance was not improved in a 
statistically significant way for the investor who considered political variables.  The 
researchers concluded that, even though political variables are often included in a 
forecasting model, consideration of these variables does not help guarantee an investor 
18 
 
will profit from the stock exchange.  The authors imply that political anomalies do not 
necessarily convey market inefficiency.  
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Chapter 3:  Online Stock Market Simulators 
Stock market simulators have been around since the market originated, but with 
the arrival of computers and the internet came the first online stock trading websites. The 
first online stock trade was made by a dentist in Michigan on July 11, 1983 and was the 
first trade for Trade*Plus.  Nine years later, Trade*Plus was the fastest growing company 
in Silicon Valley; it was renamed E-Trade Group in 1996. 
 Prior to this innovation, most stock simulations were done with paper and pen, 
organized by companies and by individuals.  With the arrival of online stock trading, 
came the need for an online simulation of this trading, and in time, the first stock market 
simulation was created.  These simulations served as ways to introduce potential 
investors to the market in a no-risk, learning environment.  Most are targeted towards 
college or younger students.  
Stock Market Simulators can be broken down into two basic categories: Financial 
Simulators and Fantasy Simulators/Exchanges.  
Financial Simulators, such as eInvesting.com’s simulator, Stocksquest, or 
Investopedia.com’s simulator attempt to emulate the real stock market.  They allow users 
to invest fantasy money into real stocks, creating a portfolio that changes with the market 
realistically over time, as if the user was investing real money. All simulators have a 
delay time (usually about 20-minutes) so that trade data found with the simulator cannot 
be used to trade actively on a competing real money system.  Broker fees and 
commissions are also included in most simulators in order to more accurately affect an 
investor’s bottom line.  This helps the user consider the costs and fees associated with 
each purchase so they can trade more realistically. 
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Financial Simulators give users a feel of what investing is actually like, since they 
attempt to imitate the real markets as closely as possible.  They are best for students or 
average users who have an interest in getting into real investing but do not want to risk 
any real money.  They serve best as a teaching tool, and therefore are ideal for this 
project.  
Fantasy simulators and exchanges, such as The Hollywood Stock Exchange or TV 
Stocks Online stock exchange, TerrorXchange, or GolfInvestors, are simulators in which 
users trade fantasy stocks, which represent items that would never be traded in actual 
markets.  This could be stock in upcoming movies, television shows, directors, 
professional golfers, or even predictions of upcoming news events and possible terrorist 
attacks. 
The main difference between fantasy simulators and financial simulators is that 
although stocks can be purchased in fantasy simulators with fantasy money on some sites, 
most of them require users to trade with real money instead of fake money.  This creates 
a real market out of fake commodities.  Because of this, many of these sites are 
considered gambling sites and have been shut down in the US or moved overseas to 
avoid legal troubles.  These do not serve well as ways of learning the market, since the 
commodities traded are not tangible or practical. 
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Chapter 4: Diversified Portfolio Utilizing Fundamental Analysis 
4.1 Strategies employed 
The banking sector took a huge hit because of the subprime lending crisis in 2007.  This 
crash caused a bear market.  Bank stocks were particularly affected by the sharp decline 
in stock prices.  For example, in March of 2009, Bank of America (NYSE: BAC) stock 
bottomed out at $2.53 per share while Citigroup (NYSE: C) hit a low of $0.97.  At their 
lowest point, the panic that had hit Wall Street resulted in the severe undervaluation of 
corporate bank shares.  These stocks have made significant gains in the past six months; 
however, these stocks are still being undervalued, and they present a good opportunity for 
investment. 
4.2 Companies Chosen and Reasons 
Bank of America (NYSE: BAC) 
Bank of America Corporation was created in 1998 after the incorporation of NationsBank 
Corporation into the BankAmerica Corporation.  Bank of America can be divided into its 
three respective divisions--Global Consumer and Small Business Banking, Global 
Corporate and Investment Banking, and Global Wealth and Investment Management.  
Bank of America possesses a strong market share in all 50 of the United States and 
maintains operations abroad in 44 foreign countries.  The majority of Bank of America’s 
revenues come from consumer and small business banking, which accounted for 80% of 
the bank’s revenue in 2008.  This provides a relatively stable platform for the bank to 
capitalize on other, more risky opportunities. 
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Bank of America is a smart investment, as it is now relatively low priced.  In the past ten 
years, shares of Bank of America have not been lower in price, yet the recent acquisitions 
and announced acquisitions of Merrill Lynch and Wachovia Financial should increase the 
bank’s market share as the economy recovers.  Additionally, its position as the largest 
bank in the United States has helped to reduce the risk of investing in Bank of America.  
The current administration has shown that it will come to the aid of Bank of America if it 
shows signs of faltering to help stabilize the economy.  Though government involvement 
in Bank of America may hinder or slow current operations, it significantly reduces the 
risks involved in investment. 
Royal Bank of Canada (NYSE,TSX: RY) 
The Royal Bank of Canada began as the Merchants Bank in Halifax in 1864.  Later, in 
1901, the name was changed to the Royal Bank of Canada, and through a series of 
mergers and acquisitions, has become the largest financial institution in Canada.  The 
Royal Bank of Canada divides its operations into five divisions—Canadian banking, 
wealth management, insurance, international banking, and capital markets (shown in 
order of decreasing percentage of total revenue).  The Royal Bank of Canada’s Canadian 
banking division reaches 10 million customers, totaling C$2.6B during fiscal year 2008.  
This accounted for 43% of the company’s total revenue that year. 
Canada has instituted stricter regulations on banking practices than other nations.  For 
example, Canada requires a tier-1 capital ratio of at least 7%.  Canadian financial 
responsibility is also an important factor in the success of the Royal Bank of Canada.  In 
a report published by the CBA’s Mortgage Bankers' Association in July 2008, Canadian 
23 
 
loan delinquency rates averaged 0.29 %, compared to 2.20 % in the United States.  
Though Canadian banks were not unaffected by the recent recession, the more sheltered 
climate of the Canadian banking sector has helped Canadian banks to post better relative 
profits and revenues than their foreign counterparts in the recent economic turmoil.  This, 
and a strong Q3 2009 net margin of 16%, helps make investment in the Royal Bank of 
Canada a smart decision. 
Reasons for Investing in Brokerage Firms 
The recent recession has resulted in the frequent trading of large volumes of stocks.  
Brokerage companies earn most of their revenue from transaction fees made when stocks 
are trade.  Thus in a volatile economic climate where stocks are often bought and sold at 
short intervals, investment in brokerage firms is a relatively safe decision. 
TD Ameritrade Holding Corporation (NYSE: AMTD) 
Toronto-Dominion Ameritrade began as a small investment bank in Delaware in 1971.  
Through the subsequent acquisitions of Aufhauser and Company (a company with one of 
the first platforms for secure internet stock trading) and Toronto-Dominion Waterhouse, 
TD Ameritrade has become one of the largest and most successful brokerage firms in the 
world. 
Though common to the industry, TD Ameritrade has posted many consecutive high net 
margins (~25%).  This, combined with a high interest coverage ratio of 12.9 
(wikinvest.com September 19, 2009), makes TD Ameritrade one of the safest 
investments in a very lucrative industry. 
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SEI Investments Company (NASDAQ: SEIC) 
SEI Investments Company is an investment company that specializes in software 
development and administration to both large companies and wealthy investors.  SEI 
Investments offers a broad range of financial software, ranging from accounting to 
investment solutions, to its customers.  SEI Investments maintains an administrative role 
over its software solutions, at a fee.  The company’s net margin has increased rapidly 
since the recession and has recovered to 16.5 % from a low of 3.6 % in the fourth quarter 
of 2008.  SEI also boasts an impressive interest coverage ratio of 47.4 % and an ROA of 
9.1%, making SEI Investments Company a sound investment. 
Baidu.com (NASDAQ, ADR: BIDU) 
As the successes of Goggle.com have shown, there is a large market for internet search 
providers who take advantage of advertising space.  Baidu.com has become the largest 
Chinese language search provider on the internet and is consequently the most visited site 
by Chinese users.  As China continues to industrialize and revolutionize, more of China’s 
large population can gain access to both the internet and to Baidu.com.  Baidu.com is a 
good investment, as Baidu.com is well-positioned take advantage of the already lucrative 
business model of Google.com while its number of users continues to grow and expand 
with China’s booming economy. 
Reasons for Investing in a Stock Market Index (DJIA) & (QQQQ) 
The recession that has hurt stock prices is seeming to end.  The president has forecast that 
recovery will occur into 2010.  With this assumption, it is likely that the stock market as a 
whole will continue to recover much of the ground that it had lost during the recession.  
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Thus, with the assumption of a stabilizing and once again growing economy, a stock 
representing a trading index as a whole is a logical investment.  Price weighted averages 
of composite indexes reduce the risk of investing as if one company fails, the others in 
the index can help offset the loss. 
Therefore, investing in the Dow Jones Industrial Average (DJIA) or the Power Shares 
QQQ Trust, Series 1 (NASDAQ: QQQQ) would be a reasonably safe and intelligent 
decision. 
4.3 Weekly Simulation Reports 
 
4.3.1. Journal for Week of Sept. 21 – Sept. 27, 2009 
This week I did not make any trades beyond the initial purchase of my stocks. 
Table 4.1. Transaction History  
Date Symbol Buy/Sell Price Shares Net Cost/ 
Proceeds 
Total Cash 
9/21/09      $500,000.00 
9/21/09 AMTD Buy $19.45 5000 ($97,269.99)) $402,730.01 
9/21/09 AMTD Buy $19.46 2500 ($48,669.99) $354,120.02 
9/21/09 QQQQ Buy $42.56 1500 ($63,859.99) $290,260.03 
9/21/09 BIDU Buy $398.58 125 ($49,842.49) $240,417.54 
9/21/09 BAC Buy $17.29 4500 ($77,824.49) $162,593.05 
9/21/09 RY Buy $52.78 1500 ($79,189.99) $83,403.06 
9/21/09 SEIC Buy $19.55 4100 ($80,174.99) $3,228.07 
 
As seen in Table 4.1, I purchased the majority of my stocks in the banking/investment 
sector.  I believe that as the economy rebounds, the first companies to see share price 
increases will be those who were first hit when the stock market crashed.  I allocated the 
largest share in Ameritrade.  This is because Ameritrade makes the majority of its 
revenues from stock transaction commissions.  If the economy continues to change, either 
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up or down, Ameritrade will make money off of the stock trade commissions.  When the 
market is more volatile, AMTD makes more money as more trades are made.  This 
purchase will act as a sort of safety net for my portfolio in case the market crashes. 
I allocated the least amount of my money in Baidu.com because I believe that their stock 
price may have reached a zenith.  Baidu.com has unlimited potential in the Chinese 
market, yet their stock has increased so rapidly in the past year that it is at risk of falling 
due to an overinflated share price.  Thus to be cautious, I have limited the number of 
shares I have initially purchased from Bidu.com.  The remainder of my $500,000 was 
divided evenly amongst the remaining companies. 
4.3.2 Journal for Week of Sept. 29 – Oct. 2, 2009 
This week, the stock market, as a whole, decreased in value.  Stock prices fell after the 
Department of Labor released a worse than expected jobless claims report in which new 
jobless claims were 3% higher than expected.  This compounded a problem that had 
started with a worse than expected report on private sector job losses that was released 
earlier in the week.  These reports have made investors cautious about the continuous 
gains that the stock market has made in the last quarter.  The banking sector took a 
particularly large hit and as such, my portfolio’s total value has shrunk. 
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Table 4.2. Portfolio Value to Date 
Date of 
Valuation 
Symbol Current 
Price Per 
Share 
Shares Total Value 
9/21/09 AMTD $19.36 7500 $145,200.00 
9/21/09 QQQQ $40.88 1500 $61,320.00 
9/21/09 BIDU $375.21 125 $46,901.25 
9/21/09 BAC $16.34 4500 $73,530.00 
9/21/09 RY $51.03 1500 $76,545.00 
9/21/09 SEIC $18.80 4100 $77,080.00 
    $480,576.25 
 
As seen in Table 4.2, the largest losses suffered this week for my portfolio were from the 
Bank of America Corporation and the Royal Bank of Canada.  Bank of America is in the 
process of finding a new CEO to replace retiring CEO Ken Lewis.  The news of Ken 
Lewis’s retirement might have contributed to the large losses of Bank of America.  
Though Baidu.com did also lose a large percentage of its value, I did not invest very 
strongly in this company, and so the losses incurred from Baidu.com are nominal.  TD 
Ameritrade shares were relatively unaffected by the downward trend of the stock market 
in the past week.  The high volume of shares that was traded this past week should help 
increase their revenue.  I do not believe that the downward trend of the stock market this 
week is signaling another crash.  I think it is solely a reaction of cautious investors, who 
will overcome their timidity in the coming weeks.  Thus, I see no reason to sell my shares 
now, at the bottom of a slump.  Already, Bank of America has recuperated some of its 
losses and I believe will continue to do so next week (BAC shares rose 0.8%, $0.13, in 
trading on Friday (Figure 4.1)). 
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Figure 4.1. BAC Stock Chart for Week of Sept. 29 - Oct 2, 2009  
 
The increase in BAC’s share value Friday was a result of the bank’s board authorizing a 
dividend payment on preferred stocks issued to the Treasury Department last year as part 
of the bank’s rescue plan, signaling the bank’s ability to repay its TARP loans. 
4.3.3 Journal for Week of Oct. 5 – Oct. 9, 2009 
This week, the stock market, as a whole, increased in value.  The NASDAQ rose nearly 
100 points while the NYSE composite index rose nearly 360 points since the start of the 
week.  Stock prices rose as investor’s fears that the economic recovery was moving too 
quickly, lessened. 
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Table 4.3. Week End Portfolio 
Date of 
Valuation 
Symbol Current 
Price Per 
Share 
Shares Total Value 
10/9/09 AMTD $20.45 10,500 $214,725.00 
10/9/09 BIDU $427.07 25 $10,676.75 
10/9/09 BAC $17.50 7250 $126,875.00 
10/9/09 RY $53.61 1500 $80,415.00 
10/9/09 SEIC $20.07 4100 $82,287.00 
    $514,978.75 
 
As can be seen from Table 4.3, the value of my portfolio has increased by approximately 
$15,000 since starting the simulation; my shares have increased an average of 2.52% in 
value to date. 
Table 4.4. Trades Made During Simulation Week Three 
Date Symbol 
buy/ 
Sell 
Price Shares 
Net Cost/ 
Proceeds 
Total Cash 
Total 
Profit 
10/9/09      $3,228.07  
10/9/09 QQQQ Sell $42.45 1500 $63,651.86 $66,879.93 $5,281.87 
10/9/09 AMTD Buy $20.41 3000 ($61,249.99) $5,629.94  
10/9/09 BIDU Sell $426.32 100 $42,612.01 $48,241.95 $2,734.02 
10/9/09 BAC Buy $17.48 2750 ($48,089.99) $151.96  
 
I decided to sell all of my shares of QQQQ as it is a composite of the NASDAQ, and thus 
moves with the average of a group of stocks.  This reduces the risk in investing in the 
QQQQ, yet this stock usually changes value more slowly than individual companies do.  
I think that as the economy recovers, specific sectors with high intrinsic value, such as 
the banking sector, will recovery more quickly than a composite index.  Thus, I sold all 
30 
 
of my shares to invest in the riskier Bank of America, hoping for higher returns as BAC 
recovers. 
Additionally, Baidu.com stocks have risen significantly since last week (+ 13.8%), even 
hitting a 52-week high on Thursday.  I do not think that the inherent value of the 
company has increased as rapidly in such a short amount of time.  This rapid of a price 
increase is usually accompanied with by a subsequent sell-off and reduction in value. 
4.3.4 Journal for Week of Oct. 26 – Oct. 30, 2009 
Though a better than expected third-quarter GDP report punctuated this week, stocks 
ended down this week.  The Dow tumbled 249.85 points (-2.51%) this Friday; the 
NASDAQ (-52.44) and S&P (-29.93) both ended the week with a slide as well.  It seems 
that the recent selloff was due to investors concerns over the validity of the recovery that 
has been ongoing since the summer.  This is evidenced by the decline that followed the 
seemingly optimistic third-quarter GDP report. 
As can be seen from Table 4.5, I sold my Biadu.com, Bank of America, Royal Bank of 
Canada, and SEI Investments Co. stocks.  From these sales, I purchased equivalent 
amounts of Raytheon and Activision Blizzard stocks. 
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Table 4.5. Trades for the Week Of Oct. 26, 2009 
 
Table 4.6. Week End Portfolio 
Date of 
Valuation 
Symbol Current 
Price Per 
Share 
Shares Total Value 
10/30/09 AMTD $19.73 10,500 $202,650.00 
10/30/09 RTN $45.50 2,800 $126,784.00 
10/30/09 ATVI $10.87 12,000 $129,960.00 
    $459,394.00 
 
Baidu.com’s profits rose 42%; however, the company’s fourth quarter revenue projection 
of $174 - $180 million was considerably below the expected projection of $205 million. 
This caused shares to fall 11.42%.  The company cited the ailing world economy as a 
reason for this shortfall.  I sold my few remaining shares of Baidu.com because it is still 
plagued by the recession.  Advertising, where Baidu.com makes most of its revenue, is a 
discretionary expenditure that is curtailed during a recession.  When recovery returns to 
the world market, Baidu.com will once again be a strong stock to purchase. 
Though Bank of America appears to be a good investment (20.3% projected revenue 
growth), investors are weary of a continued rally.  This skepticism, even in the face of 
higher than expected Q3 GDP growth, has caused bank stocks to be seriously 
undervalued.  Bank of America is a relatively safe investment in the long-term as the 
Date Symbol buy/ 
Sell 
Price Shares Net Cost/ 
Proceeds 
Total 
Cash 
Total Profit 
      $151.96  
10/30/09 SEIC Sell $17.44 4,100 $71,484.01 $71,635.97 ($8,651.00) 
10/30/09 RY Sell $50.49 1,500 $75,715.01 $147,350.98 ($3,435.00) 
10/30/09 BAC Sell $14.74 7,250 $106,845.01 $254,195.99 ($19,069.47) 
10/30/09 BIDU Sell $380.87 25 $9,501.76 $263,697.75 ($442.75) 
10/30/09 RTN Buy $45.50 2,800 ($127,419.99) $136,277.76  
10/30/09 ATVI Buy $10.87 12,000 ($130,459.99) $5,817.77  
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largest investment bank in the United States.  However, in the short-term, Bank of 
America is not a good investment, as its shares are too volatile and change value 
drastically as investors hopes and concerns wax and wane.  Similarly, Royal Bank of 
Canada has posted a net income in Q3 of 2009 of $1.49 B, the highest of the past 10 
quarters.  However, Royal Bank of Canada’s shares have faced similar problems due to a 
lack of investor confidence.  Thus, I have elected to sell these shares until investor 
confidence in the banking sector returns. 
I have chosen to purchase Raytheon shares as the company is well poised to ride out the 
recession due to its technology-driven product line and large volume of backordered 
contracts.  Though the wars in the Middle East, that the United States is involved in, may 
be ending, Raytheon will not suffer as defense spending is reduced.  Most likely, these 
changes will be seen in companies that produce low-tech products like bullets and body 
armor.  Raytheon produces advanced sensors and defense systems that are important in 
today’s world and will become more important as the threat of warfare becomes more 
decentralized.  Additionally, 95% of the company’s revenue has come from its major 
contracts, while less than 5% of revenue has come from the company’s other outstanding 
15,000 contracts.  Should the company experience problems with its current major 
contracts, it could potentially shift its focus to one of these other contracts to make up 
profits.  Lastly, the company’s large backlog of $38.9 B likely indicates that the 
company’s sales are higher than usual. 
As the economies of the United States and Europe recover, Activision Blizzard is likely 
to experience significantly increased profits, especially if the recovery continues through 
the holiday and summer months, when the majority of new games are sold.  With the 
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company’s Guitar Hero and Call of Duty franchises, Activision Blizzard maintains an 
effective revenue source.  In particular, the newest game in the Call of Duty series, 
Modern Warfare 2, is expected to sell a record number of copies.  As of August 5, the 
game had already broken Activision Blizzard’s own record for number of presales with 
14 million copies already purchased.  The number has certainly increased since August 5 
in anticipation of the game’s release on November 12.  Additionally, the sequel to the 
best selling real time strategy game of all time, Starcraft II, is due to be released in 2010 
by Activision Blizzard.  This will also significantly increase the company’s profits.  In 
anticipation of the releases of these products, I purchased shares in Activision Blizzard. 
4.3.5 Journal for Week of Nov. 2 – Nov. 6, 2009 
This past week, the stock married rallied.  This rally was primarily a result of better-than-
expected profit and economic reports, the government’s decision to extend 
unemployment benefits, and the homebuyer tax credit.  My portfolio also increased in 
value this week, as can be seen in  Table  4.7.  From last week, the value of my portfolio 
has raised $4,500.00 from $459,394.00. 
Table 4.7. Week End Portfolio 
Date of 
Valuation Symbol 
Current 
Price Per 
Share 
Shares Total Value 
11/6/09 AMTD $19.86 5,250 $104,265.00 
11/6/09 RTN $45.57 2,800 $126,784.00 
11/6/09 ATVI $11.25 12,000 $129,960.00 
11/6/09 SEIC $18.05 5,700 $102,885.00 
    $463,894.00 
 
Raytheon and Activision shares are largely responsible for this increase.  Since I 
purchased shares in Raytheon Co., shares have risen 4.55%.  Likewise, since I purchased 
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shares in Activision Blizzard Inc., shares have risen 3.50%.  Shares in TD Ameritrade 
Holding Cp. have only risen 2.88% in the past week. 
As can be seen in Table 4.8, I sold half of my shares in TD Ameritrade, 5,250 shares, to 
purchase 5,700 shares in SEI Investments Company.  
Table 4.8. Trades for the Week of Nov. 2, 2009 
 
I elected to sell some of my TD Ameritrade shares because they have remained relatively 
stagnant.  However, SEI investments has been upgraded from “market perform” to 
“outperform” by analyst Keefe Bruyette.  As can be seen in Figure 4.2, this news 
prompted a sizeable jump in stock price the following day (the time of this market 
valuation is highlighted in gold).  On hopes of SEIC shares reaching their target price of 
$22 per share, I chose again to purchase shares in SEI Investments. 
 
Figure 4.2. SEIC Stock Chart for Week of Nov. 2 – Nov. 6, 2009  
Date Symbol buy/ 
Sell 
Price Shares Net Cost/ 
Proceeds 
Total 
Cash 
Total Profit 
      $5,817.77  
11/6/09 AMTD Sell $19.86 5,250 $104,245.01 $110,062.78 $7,688.03 
11/6/09 SEIC Buy $18.05 5,700 ($102,904.99) $7,157.79  
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4.3.6 Journal for Week of Nov. 9 – Nov. 13, 2009 
During the final week of the simulation, I sold all of my stocks to evaluate whether I had 
made a profit or a loss during the simulation.  The results of this week’s sales can be seen 
in Table . 
Table 4.9. Trades for the Week of Nov. 9, 2009 
 
I chose to sell my shares of SEI Investments and purchase more shares of Activision 
Blizzard before the simulation ended because Activision stocks were rising in value 
steadily at the week’s end, due to higher than anticipated Q3 profits and record sales of 
Call of Duty: Modern Warfare 2.  As can be seen in Table , I ended the simulation with 
$497,410.34, down 0.51% from $500,000.00.  Profits from selling Raytheon and 
Activision Blizzard shares ($9,844.02 and $10,058.02, respectively) helped to recuperate 
most of the losses suffered from investments made in Bank of America in previous weeks. 
Had the simulation continued, I would have most likely sold most of my other shares in 
favor of purchasing more Activision Blizzard stocks, especially after the company earned 
$310 M in the first 24 hours of the game’s release.  With unprecedented good reviews for 
its recent releases ahead of the holiday season, this company’s stock most likely will 
Date Symbol buy/ 
Sell 
Price Shares Net Cost/ 
Proceeds 
Total 
Cash 
Total Profit 
      $7,157.79  
11/13/09 SEIC Sell $17.99 5,700 $102,523.01 $109,680.80 ($1,236.98) 
11/13/09 ATVI Buy $11.66 8,600 ($100,295.99) $9,384.81  
11/13/09 AMTD Sell $20.95 5,250 $109,967.51 $119,352.32 ($54.98) 
11/13/09 RTN Sell $49.03 2,800 $137,264.01 $256,616.33 $9,844.02 
11/13/09 ATVI Sell $11.69 20,600 $240,794.01 $497,410.34 $10,058.02 
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continue to rise in value over the next several weeks as people continue to flock to stores 
hoping to purchase Call of Duty: Modern Warfare 2. 
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Chapter 5: Investing in the Life Sciences using Company History and 
Projected Growth 
5.1 Companies Chosen and Reasons 
 
Gilead (NYSE: GLD) 
Gilead Sciences is a biopharmaceutical company that specializes in the 
development and sale of therapeutic drugs.  Some of their high earning products are 
designed for the treatment of currently incurable maladies such as HIV, hepatitis B, and 
cystic fibrosis.  These diseases represent persistent viral or genetic problems which 
plague a patient—or, from a different perspective, a customer-- for a lifetime, and require 
constant treatment. 
   One asset that makes this company an attractive prospect for investment is its 
market-leading HIV drug portfolio.  HIV is a catastrophe without rival in modern global 
health. At the end of 2006, The Joint United Nations Program on HIV/AIDS released 
these statistics about the HIV pandemic:  
 38.6 million people were living with HIV/AIDS by the end of 2005  
 In 2005, 2.8 million people died from HIV related causes.  
 In 2005, 4.1 million people worldwide became newly infected with HIV 
The hardest hit areas are Third World countries.  These populations have the least 
access to HIV prevention and treatment.  However, thanks to charitable foundations such 
as the Clinton Initiative, this access is increasing (UNAIDS.org). 
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According to Gilead.com, in July 2009, Gilead Sciences wrapped up a relevant 
study in CapeTown, South Africa.  The study explored the efficacy of HIV drugs taken in 
absence of routine laboratory monitoring available to patients in wealthier countries. 
Compared to a group that was provided with therapy, clinical monitoring and laboratory 
monitoring; a group provided with only therapy and clinical monitoring had similar 
mortality rates and renal function. Due to ethical issues, there was no control group that 
went without therapy.  However, considering the well-documented progression of 
untreated AIDS in the past, it was projected by researchers that mortality of participants 
was reduced by some 60%.  
This study indicates that HIV therapy manufacturers will continue to expand into 
the densely populated market of the Third World.  A bigger market may mean more 
profit, and an increase in stock prices. 
Another good indicator is the company’s high ROA, ROE, and interest coverage ratio.  
These statistics indicate that the company makes much more in profit than it consumes in 
equity, that it uses its assets efficiently, and that it is reliable when it comes to making 
paying debts (see below). 
Table 5.1: Stock Information: Gilead 
P/E  19.4 
EV/EBITDA 13.7 
ROA 30.5% 
ROE  49.8% 
Debt to Equity  0.616 
Current Ratio 2.25 
Interest Coverage Ratio  73.7 
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Potential threats to this company include strong competition from other drug makers, 
such as GlaxoSmithKline and Novartis.  There is also the burden of securing FDA 
approval for new innovations, legislative and regulatory changes which may outlaw or 
restrict some of its products, and generic drug substitutes which ride the coattails of its 
R&D department for quick cash.  (wikinvest.com) 
Gentech (NYSE: DNA) 
Genentech is another biopharmacutical company.  Its recent, rapid growth has been 
extremely profitable for investors: annual revenue grew by 77 percent in two years, from 
$6.6 billion in 2005 to $11.7 billion in 2007.  In the graph below, one can observe a 
drastic 30% increase in stock prices in just four months, following the release of a study 
which proved that a Genentech’s drug, Avastin, decreases mortality rates in breast cancer 
patients.  
 
 
 
 
 
Figure 5.1: Stock Prices in US Dollars over Time in Months from May 2008 
to March 2008. 
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FDA approval of new uses for two of Genentech’s drugs,  Herceptin and  Rituxan, 
have also boosted sales.  Net income and profit margins have steadily grown as the 
company's core products transitioned from development to the market (wikinvest.com).  
This investor chooses Genentech in hopes that the engineers at Genentech will continue 
to produce more popular and life-sustaining drugs. 
Genzyme (NYSE: GENZ) 
Genzmye is a biotech company that has found a niche in catering to the often-
marginalized victims of rare disorders.  Commercializing drugs for this population 
accounts for 47% of company revenues (wikinvest.com).  The company and its chief 
executive Henri Termeer, are notorious for aggressively acquiring other companies 
(thedeal.com).  Genzyme has consumed nine other biotech firms since May 2004, each 
one larger than the last.  These acquisitions have undeniably contributed to their diversity 
of products and overall value (New York Times). 
Genzyme’s two major earners are its products Cerezyme and Renagel, which 
together comprise about 50% of the company’s total revenue.  This represents a 
concentrated risk for an investor, because having only two products in such a pivotal role 
leaves the company vulnerable to competition.  Cerezyme, at least, seems forseeably safe 
from this threat.  Cerezyme is the only major therapy for Gaucher’s Disease, a deadly 
enzyme deficiency that leads to the accumulation of fat in vital organs.  Sales of 
Cerezyme continue to see steady growth because of the consistent identification of new 
cases.  No significant competition exists at this time for Crezyme, and the drug has been 
proven safe and effective (wikinvest.com).  The success of Cerezyme is the most 
attractive aspect of this company.  
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Renegal, meanwhile, which is directly competed with by the drug PhosLo by 
Fresenius, has held up well under the strain of competition. About half of the US 
population suffering from renal failure takes Renegal (wikinvest.com).  
 Below is a table of the company’s vital statistics.  Its interest coverage ratio 
reflects a high ability to pay off its debtors, which makes Genzyme seem like a stable 
company. 
Table 5.2: Stock Information: Genzyme 
P/E  27.3 
EV/EBITDA 11.0 
ROA  6.1% 
ROE  8% 
Debt to Equity  0.297 
Current Ratio  2.63 
Interest Coverage Ratio  529 
 
Celgene (NYSE: CELG) 
Celgene is a pharmaceutical company that develops and commercializes drugs to 
treat various disorders, such as blood cancers and ADHD.  Reylemid, a drug to treat 
MDS, or “pre-leukemia,” has been a particularly successful Celgene product.  Sales of 
Reylimid grew from $3 million in 2005 to over $320 million in 2006, representing nearly 
30% of the company's 2006 revenue.  However, this drug may soon lose its popularity 
due to competition from a new drug from Millemnium, which, though largely untested in 
the patient population, performed well in clinical trials.  Celgene responded to this 
potential challenge by acquiring Pharmion, a company which caters to a specific subset 
of blood-cancer patients. Pharmion’s creation, Vidaza, is prescribed to high risk multiple 
42 
 
myeloma patients, while Celgen’s Reylimid targets low risk patients. Research continues 
on better ways to improve the treatment of blood cancers (wikinvest.com). 
The main attraction to the investor is Celgen’s family of Ritalin drugs, which are 
used to treat Attention Deficit Hyperactive Disorder.  Methylphenidates like Ritalin have 
been used to treat the disorder since the 1960s.  The number of prescriptions issued, 
especially in the United States, has increased dramatically since the 1990s (Wikipedia). 
Proposed explanations for what has been termed the “Ritalin explosion” range from the 
optimistic to the cynical, but here are a few from PBS.org: 
 Pediatricians are now better able to diagnose ADHD because it has been 
well characterized. 
 Consumers have realized that the drug can be taken during and past 
adolescence, bringing adults users into the market. 
 The introduction of the first truly popular prescription psychiatric drug, 
Prozac, in the late 80s, paved the way for other psychiatric drugs. 
 In the early 1990s, the Department of Education mandated that children 
with ADHD qualify for special education, but this publically funded aid, 
such as counseling, is limited unless parents also agree to try medication 
for the disorder. 
 Regardless of the causes, the population of patients taking prescription drugs for 
ADHD is always increasing, and Celgene is providing. 
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Other reasons for picking Celgene are the company’s high current ratio and very 
high interest coverage ratio. These numbers reflect their short term and long term ability 
to make payments regarding liability and debt, indicating a stable company. (see below) 
Table 5.3: Stock Information: Celgene 
P/E  79.6 
EV/EBITDA  34.3 
ROA  6.6% 
ROE  8% 
Debt to Equity  0.230 
Current Ratio  7.34 
Interest Coverage Ratio 318 
 
Illumina (ILMN) 
Illumina is a leading provider of genomics equipment for researchers, and that 
lead is growing (finance.aol.com).  Illumina has expanded its product portfolio in the last 
few years by the acquisition of two other biotech suppliers. These were CyVera in 2005 
and Solexa in 2007 (wikinvest.com).  
The field of genetic engineering is in a state of growth, with new discoveries and 
new uses for related technologies being innovated every day. Techniques like RNA 
silencing, which uses RNA to deactivate specific genes, and Viral hijacking, which uses 
viral capsules as a system of drug delivery, consistently vitalize the industry. It is clear 
that the need for gene-related products will only increase in this climate of rapid 
discovery.  
Illumna was hit hard by the flagging economy in August of 2008. This may have 
been due to the fact that the company’s major clients are research institutions, which rely 
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heavily on government grants, and the government itself.  The amount of grants offered 
from government sources decreased during that time.  However, this stock has been on 
the rise since November of 2008, so now may be a good time to buy.  This information is 
represented graphically below: 
 
Figure 5.2: Stock Performance of Illumina 
 
Additionally, as the economy recovers, one can expect government grants to 
increase to normal or even greater than normal levels.  The current US administration has 
been very helpful to the biotech industry, with such actions as repealing the presidential 
ban on putting tax money towards stem cell research (ABCnews.com).  President Obama 
even announced in his inaugural address an intention to “We will restore science to its 
rightful place and wield technology's wonders” (New York Times). 
Other reasons for choosing Illumina as an investment target are its high P/E and 
EV/EBITA ratios, which indicate that people are already willing to pay a great deal for 
these stocks relative to how much the company makes.  In this context, these numbers 
seem to reflect Illumina’s good reputation.  They also have a high interest coverage ratio 
(see below). 
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Table 5.4: Stock Information: Illumina 
P/E  85.9 
EV/EBITDA  33.6 
ROA  5.9% 
ROE 9.1% 
Debt to Equity  0.572 
Current Ratio  2.42 
Interest Coverage Ratio  14.0 
 
5.2 Weekly Simulation Report 
 
5.2.1 Journal for Week of Sept. 21 – Sept. 27, 2009 
 
09/23/09 
Today I began my Investopedia simulation by “purchasing” stocks in the companies I had 
researched: Illumina, Genzyme, Gilead Sciences, and Celgene.  I had intended to 
purchase shares from Genentech as well, but this company was not available within the 
game.  Instead, I used the money I would have spent on Genentech to buy more shares in 
Genzyme.  The final tally was as follows (Table 5.5). 
Table 5.5: Initial Purchases 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
9/23/09       500000  
9/23/09 ILMN buy $39.72 2250 $89,389.99  427747.59  
9/23/09 GENZ buy $57.21 3508 $200,695.13  305369.17  
9/23/09 GILD buy $46.09 2173 $100,173.56  205618.42  
9/23/09 CELG buy $54.04 1850 $99,992.51  155659.56  
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As can be seen, I purchased roughly 100,000 dollars of each company, with extra 
100,000 dollars intended for Genentech going to Genzyme.  I will monitor these 
purchases and redistribute the funds according to how successful they are. 
09/24/09 
No purchases were made today.  Stocks in Genzyme, Gilead Sciences, and Celgene went 
down. Since my investment in Genzyme Is doubled, I lost more money in Genzyme than 
the others did, from its purchase value $57.21 to its closing value today at 56.63.  Stocks 
in Illumina, on the other hand, increased from its closing value on the 23rd, $40.20, to its 
closing value today, $40.36.  I am considering decreasing my investment in Genzyme and 
increasing my investment in Illumina. 
09/25/09 
Today I researched different companies involved in manufacturing vaccines against the 
swine flu.  This strain of H1N1 has caused a lot of concern in my community and 
globally, and it seems like everyone is eager to get a vaccine.  According to cnn.com, the 
World Health Organization is admonishing wealthy nations who have ordered too much 
vaccine, because the demand for this good far outpaces the supply.  Also according to 
cnn.com, four companies on the New York Stock Exchange who are making the vaccine 
at present are AstraZeneca (AZN) Novartis (NVS), GlaxoSmithKline (GSK), and Sanafi-
aventis (SNY).  To purchase them, I used funds that had been tied up in Genzyme and 
Celgene.  I made the following trades. 
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Table 5.6: Purchasing Stock in Swine Flu Vaccine Manufacturers 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
9/25/09 SNY buy $36.74 1057 $38,854.17  155659.56  
9/25/09 GSK buy $39.19 998 $39,131.61  155659.56  
9/25/09 NVS buy $48.53 794 $38,552.81  155659.56  
9/25/09 AZN buy $44.17 884 $39,066.27  155659.56  
9/25/09 CELG Sell $53.46 900 $48,094.01 $475.76 155659.56 $475.76
9/25/09 GNEZ sell $56.48 1754 $99,045.93 -$938.39 155659.56 -$938.39
 
As you can see, I reduced my holdings in Genzyme and Celgene by about half, and 
distributed the funds equally between the four new prospects. 
At the end of the day, each of the four new purchases yielded profit except AstraZeneca, 
which fell from $44.17 to $43.91.  Illumina’s value continues to increase. 
09/26/09 
Because the market is not open today, I made no trades.  I took stock of my position in 
the game thus far, and how my investments have changed.   So far, I have made a profit, 
and the most profitable investment has been Illumina. 
09/27/09 
No trades can be made today, but I have decided to dedicate my remaining cash funds, 
$1,283.89, to purchasing more stock in Illumina.  I will also be reducing my holdings in 
AstraZeneca, after learning that the company plans to cut 113 jobs in Westborough 
beginning next month (according to the Boston globe article, “AstraZeneca will cut 113 
Jobs in Massachusetts.”) I theorize that this action will make the company look unreliable 
in the public eye and cause the stock to decrease in value.  
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09/28/09 
Today I followed through with plans to purchase more stock in Illumina and sell stock in 
AstraZeneca. The following trades were made. 
Table 5.7: Transactions made on 09/28/2009 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/ 
Loss 
Total 
Cash 
Total 
Profit 
9/28/09 ILMN buy $40.96 786 $32,214.55  500000  
9/28/09 AZN sell $44.98 700 $31,466.01 $2,115.00 427747.59 $2,115.00
 
I now have only about 100 shares in AZN. At the end of the day, AZN prices had 
dropped further to 44.76.  
5.2.2 Journal for Week of Sept. 29 – Oct. 2, 2009 
09/29/09 
No trades were made today.  My overall value has increased from yesterday at $500,276 
to $507,535, due to the increased value of all stocks except Astrazeneca and Genzyme. 
This is the biggest increase in my value since the start of the simulation. 
09/30/09 
Today my overall value increased again from  $507,535 to $510,006.  ILMN continues to 
outperform other investments by rising from $42.1 to $42.5. 
10/01/09 
My overall value dropped sharply today from $510,006 to $497, 900.  All stocks did 
poorly today, even Illumina.  I have searched media sources looking for an explanation, 
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for perhaps some far-reaching event that affected the market as a whole, but I have yet to 
find a smoking gun.  This may be just poor luck. 
10/02/09 
No trades were made today.  Some value was recovered when ILMN increased back to 
$42.02. AstraZeneca continues to decrease in value, now at $43.46. 
5.2.3 Journal for Week of Oct. 5 – Oct. 9, 2009 
10/05/09 
Today, all stocks other than those invested in Celgene have increased in value, ringing 
my total value back into the positive range (a .79% range).  More specifically, Gilead 
Sciences increased by 1.1%, Genzyme corp.  increased by.36%, Illumina incorporated 
increased b 2.21%y, AstraZeneca increased by1.31%, Novartis increased by .48%, 
GlaxoSmithKline increased by .36%, and Sanofi-aventis increased by 1.32%.  Celgene 
dropped by 1.15%.  I take this as a good indication that loss from last week are 
rebounding, and will probably not make any changes soon, except perhaps o invest even 
more in Illumina. 
10/06/09 
Today the first shipments of swine flu vaccines are reaching American hospitals, clinics, 
and schools.  Despite concerns over whether the vaccines are safe, many people are 
pursuing treatment for themselves and their families.  The product is in such high demand 
that shortages are expected, which could be considered positive or negative when it 
comes to evaluating the related companies.  Every one of the vaccine carriers in which I 
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invested increased in value today. I am very satisfied with this and take it as a sign that I 
made the right choice.  Perhaps flu season in general is a good time to invest in vaccine 
manufacturers, a lesson for future investing. 
10/07/09 
No trades were made today.  Illumina unexpectedly dropped in value, but I am hoping 
that was merely a hiccup in what has been a clear road to profit with this company.  
10/09/09 
No trades were made today.  Overall, this week has been very successful.  My total value 
has increased to $507, 800.75, up from the depths of last week when I had lost money. I 
am considering investing more money in Novartis and Illumina, which have been the 
highest earners, while drawing money away from Gilead Sciences and Genzyme, which 
have actually cost me money (totaling about 3000 dollars).  I will set up a trade to that 
effect on Sunday evening to take place Monday morning. 
5.2.4 Journal for Week of Oct. 26 – Oct. 30, 2009 
10/26/09 
No trades were made today.  Illumina’s decline since October 22 is beginning to concern 
me.  My most successful stock is plummeting.  At this point, I am going to stay with it 
since this stock has been so successful in the past, but soon I may be forced to sell. 
10/30/09 
51 
 
Today, I am selling two stocks in their entirety, Illumina, and GileadSciences. The reason 
for Illumina’s tumble from grace can be explained by their reported guidance for next 
year.  According to Wikinvest.com, the company has changed its projected revenue from 
$720 million down to $651 million.  As for my selling of Gilead Sciences, this stock has 
been performing mostly in the negative since the beginning of the simulation, with 
infrequent large jumps in profit.  I do not want to risk this turning into a disaster, so I am 
selling it now for a loss of about seven dollars. 
Table 5.8: Transactions made on 10/30/2009 
Date Symbol 
buy
/ 
Sell 
Price Shares 
Net Cost/ 
Proceeds 
Profit/ 
Loss 
Total 
Cash 
Total 
Profit 
10/30/09 GILD Sell $32.97 3036 $100,076.93 ($6,949.56) $466,085.80 ($33914.30) 
10/30/09 ILMN Sell $42.91 2173 $93,223.44 ($21,59.00) $465,760.09 ($43239.81) 
 
5.2.5 Journal for Week of Nov. 2 – Nov. 6, 2009 
11/2/09 
Today I researched why one of my stocks, Genzyme, has dropped so much since the start 
of the simulation.  According to wikinvest and the Wall Street Journal, contamination in 
one of Genzyme’s major plants has caused repeated delays in shipping, causing a loss of 
profits.  They recently announced that their third quarter profits would be 87% less than 
previously projected, causing many investors to lose confidence.  This occurred despite 
the announcement of a novel new drug.  In cooperation with a Netherlands based 
innovator, Genzyme admitted its first patient for testing its new drug in late October. The 
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drug is designed to penetrate the blood-brain barrier, or BBB, and deliver a toxin that 
targets Goucher’s disease.  
 Since the announced loss in earnings has already been made, however, I project that any 
further changes in this stock will be a recovery in the opposite direction. 
11/3/09 
Today on Mad Money, a television personality gave a promising review of Celgene. His 
analysis was base on the fact that there is a conference coming up on December 5th where 
leading makers of blood cancer drugs, like Celgene, will be comparing notes. 
Speculations on what Celgene has been working on may drive stock prices upwards, and 
the fact that this phenomenon has been mentioned on TV makes it even more likely.  
Trading the stock just before the conference could protect one from s devastating drop. 
Although it is currently down in vale by about 1%, I plan to take this advice and hold 
onto this stock until the end of November.  
11/4/09 
Novartis has been one of the most successful stocks have purchased.  Today, they paid a 
large bid to gain control of an 85 percent stake in the Chinese vaccine maker Zhejiang 
Taiyuan Bio-Pharmaceutical.  The Swiss company has expressed an interest in cornering 
the emerging inoculations market, perhaps because of the success which news agencies 
and healthcare officials have alarmed consumers about the dangers of epidemics.  Further, 
they recently announced they would be spending more than a billion dollars building 
plants in China.  Investors seem to think that a growing company is a healthy company.  
Below, you can see a graph of the upward trend Novartis has taken since July. 
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Figure 4.3: NVS Stock Continues to Increase 
11/5/09 
GlaxoSmithKline continues to turn a modest profit. It has recently gained attention as the 
first and only producer of an approved swine flu vaccine in all of Saudi Arabia.  Other 
drugs from other companies are available, but they have yet to gain the approval of the 
equivalent of our FDA. 
Mecca, a site for massive pilgrimages for Muslims, tends to be very congested with 
highly mobile traffic, which could potentially make it a hotbed for spreading disease. For 
this reason, some Saudi officials have come out in favor of inoculations.  However, they 
have to contend with negative propaganda accusing all vaccinations as Western attempts 
to emasculate Muslims.  
11/6/09 
Today, Business week reported that the Boniva Ad campaign, which encourages patients 
to ask their doctor about an osteoporosis drug manufactured by GlaxoSmithKline, has 
been the most successful ad campaign this year.  In a study that anonymously collected 
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data from patient doctor conversations, Boniva was the most asked for drug.  However, 
the article concludes that most drug ad campaigns have a negative effect on dug 
purchases, probably due to the legal precaution requiring companies to disclose 
information about potential side effects in their ads.  Sales of Ambien, a drug 
manufactured by Sanofi Aventis, fell by 37% after a memorable ad campaign that 
cautioned views abbot sleep eating. 
5.2.6 Journal for Week of Nov. 9 – Nov. 13, 2009 
11/9/09 
Today, the US Supreme court will be hearing a case that could potentially cause a lot of 
damage too many companies.  This issue at stake is the rights of companies to use 
abstract ideas that were developed from outside their companies.  For example, in the 
field that my stocks have specialized in, one company might use information about a 
gene sequence that another company uncovered.  Can this information be property?  
Novartis is arguing in court that yes, it should be, and ruling otherwise would “discourage 
innovation.”  On the other side of the bench are companies that are desperately trying to 
head off infringement suits.  These companies, who have been using the ideas of others 
all along, might be healed responsible for violating intellectual property.  They would be 
responsible for many damages, and I would expect thief values to plummet. 
11/10/09 
The first information release in preparation for the ASH meeting referenced in last 
week’s journal occurred today.  Scientists made the abstracts of the papers available, that 
they will be presenting to the other researchers with whom they will be meeting.  I’m 
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hoping that it will have a positive effect on the Celgene stock. Reclaimed, the blood 
cancer drug produced by this company is being researched for its dose-de [pendent 
effects. One topic at the conference will be how much Relvamid does a cancer patient 
need, and does its use outweigh its side effects?  
11/11/09 
Today, a press release from Genzyme announced that they and a partner company, Isis, 
will be presenting data about phase 3 trials of a new drug to the AHA. Depending upon 
the results of thief evaluation, Genzyme slur could go up or down. My plan is to keep the 
stock, in case speculation drives the price upwards.  However, I would sell this stock 
before November 17, which is when the AHA all is releasing their decision.  For me, it is 
not worth the risk.  Also today, GlaxoSmithKline’s swine flu vaccine won US approval.  
Surprisingly, this was not followed with a large increase in stock value. 
11/12/09 
According to the Boston Globe, Sarnoff-Aventis has been trolling for business partners.  
Looking for small startup companies that may want to combine their ideas with Snafu’s 
funding, the company is seeking to grow.  Like Genzyme, Snafu’s strategy is to grow 
larger by assimilation.  This may be a sign of stagnation in their native research and 
development departments, but whatever the reasons, acquiring new blood can only be a 
boon to the company.  
11/13/09 
Today, a poll in Weekly showed that 62 percent of Americans are dissatisfied with the 
rate at which the H1Ni flu vaccine it reaching the market.  While it is true that none of the 
companies have been able to meet their set deadlines, this is mostly due to characteristics 
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of the virus itself.  Unlike the rescuer seasonal flu virus, it does not multiply as quickly.  
In addition, US consumers are reluctant to embrace adjuvant technology, a nasal spray 
form of the vaccine.  This vector would allow drug makers to produce more vaccines, 
each with less actual virus, but which are allay effective. 
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Chapter 6: Video Game Industry Stocks with Historically Strong 
Market Performance 
6.1 Strategies Employed 
I chose stocks that have historically done very well, choosing primarily from 
companies that are involved in the video game industry in some way, since I know the 
industry well and follow it regularly.  I found the top publishers as well as the top console 
developers based on how they have performed in the market over the years and recently.  
However, I wanted to diversify a bit so my final choice was from outside this area.  
Because most video game sales come near the end of the year starting in the holiday 
season with Thanksgiving, I think these companies would be a wise place to invest for 
our simulation, which will be ending in the later part of the year. 
6.2 Companies Chosen and Reasons 
Activision-Blizzard (ATVI) is a publisher and distributor of video games for the 
PC and video game console markets.  Activision’s largest franchises include the Guitar 
Hero, Tony Hawk, Quake, and Call of Duty series.  In 2007, three of the top-10 selling 
games were Activision Titles 
 In December 2007, Activision announced it would be acquiring Vivendi’s video 
game division, Blizzard, in a deal that resulted in Vivendi owning a majority of shares in 
Activision.  Blizzard is a publisher of popular games like the Starcraft and the Diablo 
series, as well as its major online game, World of Warcraft.  The addition of Blizzard 
created a larger company, allowing Activision to compete with Electronic Arts (its 
primary competitor) more efficiently in the online gaming market.  In addition, because 
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World of Warcraft charges a monthly fee, the company is now able to make money in 
China, whereas before many companies have been unsuccessful because of the large 
amount of software piracy. 
 Activision-Blizzard has stuck to a simple formula of developing successful game 
franchises and launching a series of sequels, due to the video game industry’s striking 
similarities to the movie business.  Because a game has to do well in order to make 
money, and there is no money made during development, it is very risky for a company 
to constantly release games that do not lead to franchises.  This formula has allowed 
Activision-Blizzard to stay on top of the industry along with its major competitors. 
 Activision’s stock peaked at 18.62 in July of 2008, and is currently trading at 
11.79, leaving a good amount of room for growth.  The 52-week low price was 8.14, so at 
the very least, it seems to be steadily growing back towards where it was.  With the 
consistent success of World of Warcraft and a good deal of hyped games coming out in 
the next few months, Activision-Blizzard is going places, fast.  To me it seems like a very 
good company to invest in. 
Table 6.1: Stock Information: Activision-Blizzard 
Company  Activision-Blizzard 
Market Cap ($ Millions)  14,990  
Avg Volume (3 Month) (1000s) 151 
52-Week High Price  15.39  
52-Week Low Price  8.14  
Current Price 11.79 
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 Konami Corporation (KNM) was founded in Osaka, Japan in 1969 by Mr. 
Kagemasa Kozuki.  It has seen most of its success over the last fifteen years with the 
Metal Gear series, Castlevania series, Suikoden series, Contra series, and Silent Hill 
series.  
Its first foray into the video game industry was in October 1982, when it began 
manufacturing and selling PC games.  Its first real success, however, came when the 
Famicom became popular and was released in the United States as the Nintendo 
Entertainment System.  Most of the most popular and best-selling games for the system 
were created by Konami, including Metal Gear, Contra, and Castlevania.  At the time, 
Nintendo limited third party companies to only five games per year, but Konami 
managed to double this number by creating a quasi-independent subsidiary corporation 
known as Ultra Games.  This allowed Konami to continue to dominate the third party 
publisher industry, which was still relatively new at the time. 
Konami’s success has continued into recent years, standing the test of time and 
remaining on the top of the market along with its competitors.  Its most recent success, 
Metal Gear Solid 4, has shipped over 3 million copies worldwide since its release.  In 
addition, the game was bundled with the Playstation 3 console, which helped increase 
sales of the system, which has historically not sold very well.  As of now, the game is the 
best selling PS3 exclusive game, which is a good sign for Konami.  
Konami has done very well historically, and its stock peaked at 42.4 in 2008.  It is 
currently trading at 20.80, up from a low of 12.97 in early 2009.  This leaves room for 
growth, and the steady increase over the last few months seems to indicate that the 
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company is doing well.  The coming months are usually the best for the video game 
industry, with most of the big releases coming out near the holiday season.  This means 
Konami has nowhere to go but up, and I think it would be a good company in which to 
invest. 
Table 6.2: Stock Information: Konami 
Company  Konami 
Market Cap ($ Millions)  2,790  
Avg Volume (3 Month) (1000s) 1.879  
52-Week High Price  26.64  
52-Week Low Price  12.77  
Current Price 20.80 
 
Take-Two Interactive Software, Inc. (TTWO) is a leading worldwide publisher, 
developer and distributor of video game software, hardware and accessories. Some of 
their biggest franchises include Sid Meier's Civilization, Max Payne, Midnight Club, 
Manhunt, Red Dead Revolver, BioShock, Sid Meier's Railroads!, Sid Meier's Pirates!, 
and Top Spin.  Licensed brands include the sports games Major League Baseball® 2K, 
NBA® 2K, and NHL® 2K.  
It is best known for its Grand Theft Auto franchise, which has sold over 66 
million units across the multiple titles and is highly controversial due to its extremely 
violent subject matter.  Grand Theft Auto 4, the newest title in the series, earned more 
than $500 Million in its first week of release.  In 2008, competitor Electronic Arts offered 
to buy out Take-Two, but the board rejected the initial offer due to expected strong sales 
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of Grand Theft Auto 4.  After the game’s release, Take-Two’s stock price rose above 
EA’s offered price 
The success of Bioshock and its expected sequel also seem to indicate that Take-
Two will be able to hold its own as an independent company, especially given the hit-
driven nature of the industry.  Its stock is currently trading at 11.73, down from a peak of 
26.5 in 2008.  There seems to be room to grow, and it has grown from a 52-week low of 
5.83 to where it is now so it seems to be in good shape.  Given the hype of Bioshock 2 
and other games coming out in the next few months, I think buying stock in Take-Two is 
a very good choice. 
Table 6.3: Stock Information: Take-Two 
Company  Take-Two 
Market Cap ($ Millions)  952 
Avg Volume (3 Month) (1000s) 1,346 
52-Week High Price  17.31  
52-Week Low Price  5.56  
Current Price 11.73 
 
Electronic Arts (ERTS) is the world's largest publisher of video game software.  
EA has risen to the top mostly due to its success with acquisitions of licensing rights to 
games and studios, including top developers such as Bioware and Mythic Entertainment.  
EA’s attempt to acquire Take-Two was most likely born out of the need to create hit 
games to stay ahead of the competition.  However, the takeover was abandoned on 
August 18, 2008 after Take-Two did not accept the given offer. 
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In 2008, the company distributed its new hit franchise, Rock Band, which 
accounted for 10% of the company’s overall revenue during the year. This was followed 
by Rock Band 2 the next year, and the Beatles Rock band the year after that, securing the 
series as a key franchise in EA’s operations.  With the success of this and other major 
titles, such as Madden NFL, Need for Speed, Command & Conquer, Battlefield, Spore, 
Pogo.com, and Fifa, EA doesn’t seem to be losing its edge. 
 EA operates under a few publishing labels, including EA Games, EA Sports, The 
Sims, and EA Casual Entertainment.  
Historically, EA’s stock has consistently done very well.  It suffered like many 
other companies during the recession, but seeing as how most successful video games are 
released during the end of the year, it has nowhere to go but up with the recent release of 
The Beatles: Rock Band and the future releases it has in store.  It is currently trading at 
18.71, up from a 52 week low of 14.24, and its peak in the last three years was at 61.4, 
leaving a very large amount of room to grow.  I think at this point, the stock is priced 
very low and will only increase in the coming months, making it a wise investment 
choice. 
Table 6.4: Stock Information: Electronic Arts 
Company  Electronic Arts 
Market Cap ($ Millions)  6,050 
Avg Volume (3 Month) (1000s) 6,512 
52-Week High Price  45.10  
52-Week Low Price  14.24 
Current Price 18.71 
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Nintendo (NTDOY) originally started as a Japanese company selling playing 
cards over a hundred years ago, and eventually grew into one of the biggest companies in 
the video game industry.  Its biggest success came when it was able to survive the 
infamous Video game crash of 1983 with the release of the Famicom (Family Computer) 
video game console in Japan.  In 1985, the Famicom was released in North America as 
the Nintendo Entertainment System, the name for which it is best known for in the United 
States.  
Nintendo came out on top during those years as the most popular of the gaming 
consoles, and in 1989, the release of the Game Boy entered the company into the 
handheld gaming market, which it has continuously dominated for the past 20 years.  To 
date, Nintendo is the longest-surviving video game console manufacturer.  This gives it 
an edge over Sony and Microsoft, who are much newer comparatively. 
In recent years, Nintendo’s Wii system and DS handheld have been a part of their 
strategy to expand the consumer market for video games by creating products that are 
simple and easy to use, as well as developing games that may appeal to casual, female, 
and 35+ gamers. Both systems have been accepted by consumers and have resulted in a 
huge deal of success.  Nintendo seems to stay alive by constantly releasing the most 
innovative products that reach out to all types of consumers, and it shows no signs of 
quitting given the success of the Wii. 
As of now, Nintendo is trading at 33.61, up from a 52-week low of 32.2.  This is 
not significant, but it did peak in mid-2007 at 76.8, which leaves a significant amount of 
growth.  I think at this point, before the holiday season and the massive influx of games 
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to come out of Nintendo’s publishing section, this is a low price and a good point to buy 
at.  Holiday season of 2009 saw the stock peak at 48 (up from a low of 35.1 a few months 
earlier), which was right around the beginning of the economic recession.  If this were 
any indication, this would be a very good stock to invest in, especially for the entire 
simulation. 
Table 6.5: Stock Information: Nintendo CO LTD 
Company  Nintendo CO LTD 
Market Cap ($ Millions)  N/A 
Avg Volume (3 Month) (1000s) 70 
52-Week High Price  67.65  
52-Week Low Price  33.31  
Current Price 33.61 
 
Sony (SNE) is an international corporation with major businesses in electronics, 
video games, movies, and finance.  It began as a small Japanese electronics company, but 
rose to success after producing the first successful pocket-sized transistor radio.  Over 
fifty years later, Sony is one of the largest media companies in the world, with annual 
revenue of 86.8 billion in FY 2007.  
Based in Tokyo, it operates in the US under an umbrella company (Sony 
Corporation of America).  It is best known for being a manufacturer of home electronics, 
but it made its debut in the video game industry with the release of the PlayStation in 
1994.  This was followed by the PlayStation 2 in 2000, and the PlayStation 3 in 2006.  
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The PlayStation 2 became the most successful video game console of all time, selling 
over 140 million units. 
Although the Playstation 3 has not done as well as the Xbox 360 or the Wii in 
sales, it was a significant factor in the emergence of Blu-ray as the dominant medium for 
Hi-Definition DVDs. This has secured Sony’s place in home theater market, which is 
now almost exclusively dedicated to Blu-ray. 
Sony is currently trading at 28.46, up from a 52-week low of 16.6.  Its growth 
over the past year has not been significant, but it peaked at 56.75 in late 2007, so it still 
has a good deal of room.  I think all of this makes Sony a very good choice of stock for 
this simulation. 
Microsoft (MSFT) is the world’s largest software maker by revenue, with 60.42 
billion of revenue showing an 18% increase from 2007.  Most of its revenue comes from 
sales of Windows, Office, and Server & Tools software products.  Microsoft’s Online 
Services and Entertainment Division include the Xbox 360, Zune, and PC Software 
games, and in 2007, it saw its first operationally profitable year. 
Microsoft was founded in 1975 by Paul Allen and Bill Gates, and has been 
steadily building a dominant place in the computer industry ever since.  In 1992, it 
introduced the Windows 3.1 operating system, which created a successful revenue source 
for the company.  The release of Windows 95 and 98 again consolidated the lead in the 
industry, as did the Microsoft Office software.  Nowadays, its total desktop operating 
system market share exceeds 90%. 
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Microsoft first entered into the video game market with the release of the Xbox in 
late 2001.  The industry had been dominated by Sony and Nintendo up until that point, 
but Microsoft managed to hold its own and even followed it up with the release of the 
Xbox 360.  
Historically, Microsoft’s stock has done very well, creating billionaires out of the 
original few who were involved in initial public offering.  It is currently trading at 25.26, 
up from a 52-week low of 15.28 in mid-2009.  The past few months have seen the price 
rise at a good rate, and the price did peak in mid July 2008 at 37.08 so there is room for 
growth.  With the release of Windows 7 in the next few months, I believe Microsoft will 
do very well, and is a good choice for this simulation. 
Table 6.6: Stock Information: Microsoft Corporation 
Company  Microsoft Corporation 
Market Cap ($ Millions)  225,000  
Avg Volume (3 Month) (1000s) 68,016 
52-Week High Price  27.66  
52-Week Low Price  14.87  
Current Price 25.26 
 
PepsiCo (PEP) is a global manufacturer, distributor, and marketer of food and 
beverages.  It owns many well-known brands including Pepsi, Frito-Lay, Tropicana, 
Gatorade, and Quaker Oats.  PepsiCo owns 39% of the market share in snacks, and 25% 
of the market share in non-alcoholic beverages, making it the largest producer in both 
categories.  Despite the fact that the carbonated drink market has been declining since the 
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mid-2000s, PepsiCo has used product diversification and international expansion to allow 
it to grow.  
PepsiCo’s main advantage over rival Coca-Cola Company is that the majority of 
its revenues do not come from soft drinks.  Over 60% of the company’s beverage sales 
have come from noncarbonated brands, such as Gatorade and Tropicana, and less than 
50% of the company’s total revenue comes from beverage sales.  With a growing trend 
towards more healthy drink alternatives in recent years, this is most likely a very good 
strategy for PepsiCo. 
Seeing as how most of my investments are companies involved in the video game 
industry, I thought it would be wise to go with a company outside of the group to invest 
in for the long run.  Historically, PepsiCo has done very well and is one of the top 
companies in the food and beverage market.  Since food is a staple of human life, it 
seems as if this would be a wise, stable choice for my portfolio.  
In addition, PepsiCo shares peaked at $78.46 per share at the end of 2007, and its 
stock has only dipped down to a 52 week low of 47.1. It is currently trading at 59.86, and 
has been growing at a high, steady rate for the last few months, leaving a good deal of 
room for growth. I think this makes PepsiCo a wise investment choice for this simulation 
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Table 6.7: Stock Information: PepsiCo Inc 
Company  PepsiCo Inc 
Market Cap ($ Millions)  93,250  
Avg Volume (3 Month) (1000s) 14,646  
52-Week High Price  75.25 
52-Week Low Price  42.78  
Current Price 59.86 
 
6.3 Weekly Simulation Report 
6.3.1 Journal for Week of Sept. 21 – Sept. 27, 2009 
9/21/09 
Today was the first day of the simulation, so I had to decide how to split up the 
$500,000 I had to spend.  I decided I would start out by evenly distributing roughly 
$50,000 to each of the eight stocks, leaving me with about $100,000 to distribute later to 
stocks I felt would do the best. 
However, due to the rules of the game, I was not able to buy 50,000 worth of 
stock in Konami since that would exceed 10% of the stock’s real life trading volume.  I 
ended up only buying 260 shares, the max that I could buy, for $5,438.  This left me with 
another 44,500 to distribute once I would put 50,000 into the rest of the stocks, adding to 
the 100,000 I already had.  
I bought my first seven stocks, but due to the 20-minute time delay on purchases, 
I left PepsiCo alone until my purchases were finalized so I would have a better 
understanding of how much money I had left.  
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After my initial purchases were finished, I decided to put some more money into 
Microsoft and Activision since I felt they would do the best for me over the course of the 
simulation.  I also still had to buy stock in PepsiCo, so I put $50,000 more into Microsoft, 
and then divided up what I had left (about $144,000) into two parts and put one half into 
Activision and another half into PepsiCo. 
Table 6.8: Day 1 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
9/21/09       500000  
9/21/09 PEP buy $59.11 1222 $72,252.41  427747.59  
9/21/09 ATVI buy $12.29 9951 $122,378.42  305369.17  
9/21/09 MSFT buy $25.21 3956 $99,750.75  205618.42  
9/21/09 SNE buy $28.23 1769 $49,958.86  155659.56  
9/21/09 NTDOY buy $33.03 1511 $49,928.32  105731.24  
9/21/09 ERTS buy $18.43 2717 $50094.30  55636.94  
9/21/09 TTWO buy $11.22 4480 $50,285.59  5478.63  
9/21/09 KNM buy $20.75 260 $5,414.99  63.63  
 
9/22/09  
Because I was only able to buy about $5,500 worth of stock in Konami on the 
first day, I decided today to sell some of my stock in Activision so I would have enough 
to buy another $5,500 (the max I could for today) in Konami.  This was mostly due to the 
fact that I saw Konami was doing just about the best percentage wise of all my stocks, 
and I wanted to increase the stake I had in them to something more reasonable (instead of 
only 1% of my total starting cash) in case they continued to do better in the future. 
I took no other action, since I did not see any significant change. 
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Table 6.9: Day 2 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
9/22/09       63.63  
9/22/09 ATVI sell $12.37 445 $5,484.66 35.60 5548.29 35.60 
9/22/09 KNM buy $21.30 255 $5,451.49  30.47  
 
9/23/09 
I decided today that I needed more cash to spend on future stock purchases, since 
having about $30 to spend was nowhere near enough.  I sold about $18,000 in Activision-
Blizzard and $21,000 in PepsiCo so that things would be a little bit more even overall, 
which is how I wanted my portfolio to look in the beginning.  I ended up with about 
$39,000 in cash, enough to buy another $3,500 in Konami, which I noticed was down 
from when I initially bought it.  I thought this would be a good time to buy more, since I 
assumed it would go up in the coming days.  
After rumors that Microsoft is interested in buying Electronic Arts, EA’s stock 
went up by about 8% over the course of the day.  I saw this as a good opportunity to buy 
another 1200 shares for about $24,000, since I am hoping it will continue to go up now, 
and if any more news on a possible buyout comes out in the next few days, hopefully it 
will go up even more 
Table 6.10: Day 3 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
9/23/09       63.63  
9/23/09 PEP sell $58.78 357 $20,984.46 117.87 21014.93 117.87 
9/23/09 ATVI sell $12.53 1459 $18,279.52 350.16 39294.45 385.76 
9/23/09 ERTS buy $20.06 1200 $24,071.88  15222.57  
9/23/09 KNM buy $20.92 170 $3,556.4  11525.27  
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9/24/09 
Today, Microsoft denied the rumors that it was thinking of buying out EA.  Its 
stock dropped, prompting me to sell all the shares I had bought the day before.  I took a 
loss on the purchase, but overall I remained positive on EA so I was happy.  I took no 
other action today. 
Table 6.11: Day 4 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
9/23/09       11525.27  
9/23/09 ERTS sell $19.26 1297 $24,960.10 428.01 36485.37 428.01 
 
9/25/09 
Today I did relatively well, but Konami’s stock is continuing to drop so I decided 
to buy more shares in it to get all of my stocks to an even level for the end of the first 
week.  Next week, after the weekend has had its effect on the market, I’ll stop being so 
even with my purchase choices.  Other than that, I took no other action since I was still in 
the positive. 
9/28/09 
The weekend proved well for my stocks, as at opening my portfolio was up about 
$8,000.  I considered selling some of Microsoft, which was up about $3,000, but I am 
hoping it will continue to rise so I can make an even bigger profit in the coming days.  By 
the end of the day, I had taken no action, either buying or selling.  
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6.3.2 Journal for Week of Sept. 29 – Oct. 2, 2009 
9/29/09 
The market continued to do well today, but there was not enough of a gain for me 
to consider selling any of my shares.  I considered buying more shares in Konami, but so 
far they haven’t been proving successful for me so I decided to hold off for now.  I took 
no other action today in the hopes that things will continue to improve 
9/30/09 
Today I finally decided I would abandon my stock in Konami, since it has not 
been doing well for me and with the volume cap I haven’t been able to trade more than 
about $5,000 worth of shares per day.  It was becoming too much of a hassle.  I was only 
able to sell about $2,200 worth today, but hopefully in the coming days I can get rid of 
the rest and maybe reinvest my money in another company.  Today I also decided to 
invest about $20,000 in Sony, since they have been doing so well for me and am at the 
top of my list of stocks in terms of percentage.  Other than that, I took no action. 
Table 6.12: Day 8 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
9/30/09       36485.37  
9/30/09 SNE buy $29.31 1297 $20,018.73  16466.64  
9/30/09 KNM sell $20.22 110 $2224.21 85.80 18690.85 85.80 
10/1/09 
Today all of my stocks took a nasty turn, and all of the gains I had been making 
over the past few days are now gone.  By the end of the day, I was down about $5,000 
but I took no action.  Selling now would only result in a loss that would probably be 
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made up for in the coming weeks, and at this point, I do not have enough cash to invest in 
anything.  My plan to get rid of Konami will have to wait until the price stabilizes a bit 
more. 
10/2/09 
  My stocks dropped even lower today, bringing me down about $12,000 by the 
end of the day.  The only saving grace was PepsiCo, which is up about $1,500.  In the 
hopes that things will get better by next week, I took no action today. 
6.3.3 Journal for Week of Oct. 5 – Oct. 9, 2009 
10/5/09 
My stocks continued to drop and I continued to hold out, hoping they would go 
back up soon. 
10/7/09 
My portfolio finally bounced back up today, but it was not enough for me to take 
action.  I waited on the hopes that it would go up again soon. 
10/8/09 
Today my stocks rocketed up today, bringing my total profit up to about $10,000.  
By day’s end, I decided that tomorrow I would sell some of my best stocks and buy into a 
company that I thought was at a low. 
10/9/09 
Although I had planned to sell off and buy more today, I took no action.  I plan to 
follow through on my original plan come Monday. 
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10/13/09 
Today I decided to sell all of my shares in Electronic Arts because I was up a very 
good deal since my last purchase.  I gained $55,000 in cash, which I decided to keep until 
I found something to purchase with it. 
Table 6.13: Day 17 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
10/13/09         
10/13/09 ERTS sell $20.90 2620 $54,738.01 6,471.4 73,428.86 6,899.41 
 
10/15/09 
Today, I noticed that EA’s stock price had dropped by about 70 cents since I sold 
it, and that it was going back up after having dropped in the days before.  I decided to 
purchase another $45,000 worth of it on the hopes that it would continue to rise.  I also 
decided to sell $55,000 worth of my shares in Microsoft, since I was up about $5,000 
since I had purchased them and I hoped to secure my profits by gaining some cash. 
Table 6.14: Day 19 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
10/15/09       73,428.86  
10/15/09 ERTS buy $20.18 2966 $59,874.17  13,554.69  
10/15/09 MSFT sell $26.59 2068 $54,968.13 2,853.64 68,522.82 2,853.64 
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6.3.4 Journal for Week of Oct. 26 – Oct. 30, 2009 
10/27/09 
Today after over a week and a half without trades I decided to sell some shares to 
gain some cash from my profits. I sold the rest of my shares in Microsoft since I was up 
about $4,000 from my last sale.  I noticed that EA’s stock had dropped significantly since 
my last trade, so I decided to buy another $45,000 worth since I hoped it had reached 
something of a low and that it would continue to go back up in the future.  Finally, I sold 
all of my shares in Take-Two since I was up about $6,000. 
Table 6.15: Day 27 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
10/27/09       68,522.82  
10/27/09 ERTS buy $19.00 2371 $45,068.99  23,453.83  
10/27/09 TTWO sell $12.20 4480 $54,636.01 4,390.40 78,089.84 4,390.40 
10/27/09 MSFT sell $28.59 1888 $53,957.93 5,311.07 132,047.77 8,164.71 
 
10/28/09  
Today I bought more stock in EA, since it was dropping even lower.  I did the 
same with Activision, since it too was dropping and I hoped it had reached a low.  I 
figured with so many games coming out in the coming months the stock could only go up 
and I could make a profit on both of them. 
Table 6.16: Day 28 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
10/27/09       132,047.77  
10/27/09 ERTS buy $18.65 2733 $50,990.44  81,057.33  
10/27/09 ATVI buy $11.54 4931 $56,923.73  24,118.50  
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10/29/09  
Although I had planned to take action today, I had dropped far too much to sell 
anything.  With no available cash I did not buy anything either. 
10/30/09  
My portfolio dropped even more today, bringing me to a total of about $25,000 in 
losses. I decided to take no action since I wanted to wait until I went back up. 
6.3.5 Journal for Week of Nov. 2 – Nov. 6, 2009 
11/2/09 – My stocks continued to drop, bringing me down to about $36,000 in losses 
total.  
11/3/09 – Today My portfolio went down a bit, but it was not significant.  I am still 
around $36,000 in losses.  I took no action because of this. 
11/4/09 – I gained some money overall today, but it was not enough to take notice.  I am 
still deep in a hole and waiting for my portfolio to improve.  I took no action at all. 
11/5/09 – Today was the first day all week that I made a substantial gain, with an $8,000 
increase for the day which encouraged me.  Despite this, all of my stocks were still too 
low to take any action. 
11/6/09 – I decided to spend my remaining $24,000 today, and after looking for awhile I 
invested in Sprint Nextel, since the stock was down to about 2.85; a price I could only 
assume was just about rock bottom.  With nowhere to go but up, I bought 8,421 shares, 
the max I could with the cash that I had left.  Overall, my stocks did very well today, 
cutting my total losses to only $10,000, which encouraged me even more.  I took no other 
actions. 
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Table 6.17: Day 35 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total
Cash 
Total 
Profit 
11/6/09 N buy $2.85 8421 $24,019.84  98.66  
 
6.3.6 Journal for Week of Nov. 9 – Nov. 13, 2009 
11/9/09 – My portfolio gained quite a bit today, bringing me up about $10,000 in overall profit.  
However, I decided not to take any action today in the hopes it would go up even more tomorrow. 
11/10/09 – My decision to wait was not the optimal move, as today my stocks plummeted back 
down to about where they were on Friday.  I decided to secure some profits by selling about half 
of my stock in both Sony and Pepsi, since they were up the most out of all of the stocks in my 
portfolio.  Sprint was doing surprisingly well, but I did not foresee it going down so I did not sell 
it. 
11/11/09 – Today I noticed Sprint was doing well, but had dropped down to below what they 
were at the day before.  I took this as a sign to buy even more stock, so I bought 10,000 shares 
worth.  My portfolio continued to drop overall, so I did not take any other action 
11/12/09 – My stocks were dropping even lower, so I didn’t take any action today. Sprint has 
remained about stationary since I bought more stock in it, so I did not do anything with it despite 
the fact that it is currently in the positive. 
11/13/09 – Today being the last day of the simulation, I decided that taking action would not 
make much of a difference, especially since my portfolio was down about $14,500. 
Table 6.18: Week 8 Transaction Record 
Date Symbol buy/ Sell Price Shares 
Net Cost/ 
Proceeds 
Profit/
Loss 
Total 
Cash 
Total 
Profit 
11/10/09 PEP sell $62.00 209 $12,938.01 $604.01 13,036.67 $604.01 
11/10/09 SNE sell $29.21 719 $20,982.00 $488.92 34,018.67 $488.92 
11/11/09 S buy $3.18 10,000 $31,819.99  2,198.68  
78 
 
Chapter 7: Investing in Technology and Shoe Manufacturing Sectors 
using the Income and Growth Strategies 
 This chapter introduces and evaluates some of the technology giants and the 
world leading shoe manufacturer for investment.  Income investing and growth investing 
strategies are employed.  The backgrounds of the selected companies are described in this 
section with the reason behind each selection.  Recent performance of the companies is 
also discussed qualitatively and quantitatively.   
7.1 Strategies employed 
Income Investing Strategy 
This is the strategy by which you invest in the companies that are able to provide 
steady stream income.  It is also one of the most straightforward investing strategies in 
the stock market.  Companies that are able to provide steady income are normally the 
ones that are not expanding and have a rich history and background.  Mature firms tend 
to not reinvest themselves, but instead, they give the retained earnings to the shareholders 
as dividends.  The main reason is that the well-established firms are no longer targeting 
for any rapid expansion.  
On the other hand, income investing is not just about investing in large and 
mature companies.  More importantly, it is about investing in companies that are able to 
provide the highest dividend yield.  Dividend yield is calculated by dividing the annual 
dividend per share by share price. For instance, the dividend yields for the fortune 500 
companies are all around 2-3%.  However, the income investors demands much higher 
than that with a minimum at about 6% minimum.  In the other words, a $1 million 
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investment will have a dividend yield at about $60,000.  In conclusion, the key in income 
investing strategy is to look for good companies with sustainable high dividend yield to 
receive a steady income over the long term.  Companies such as Yahoo, Google, Apple, 
Nike, Amazon, Dell, HP, and Nokia are well-established companies with the ability to 
provide a steady stream income to their shareholders.  
Growth Investing Strategy 
 This strategy is exactly the opposite of the value strategy.  Growth strategy 
focuses more on investing the new companies with a short-term expectation that the 
company will expand rapidly.  I believe that direct growth will translate into an increase 
in stock price.  Unlike the income investing strategy, the form of profit for growth 
investors are capital gains as the young companies tend to reinvest themselves usually for 
technology innovations.  Furthermore,  there is no automatic formula to measure the 
company's potential to grow.  Growth investors use a set criterion as a framework for 
analysis.  
 There are several guidelines listed by NAIC (National Association of Investors 
Corp.).  Different growth should be expected from firms of different sizes. 
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Table 7.1: Criteria of Growth Investing Strategy 
Company Size Minimum Growth (In last 5 
years) 
> $4 Billion 5% 
> $400 Million > $4 Billion 7% 
< $400 Million 12% 
 
Additionally, the future projected growth rate should be between 10 to 12%.  However, 
since these are just the projection for future growth, the uncertainty is huge, hence higher 
risks. Companies such as Google and Yahoo have a strong potential for growth.  For 
Google, the stock price peaked at $690 before the stock market crashed, with the current 
price at $475, there is a very strong potential for growth.  For Yahoo, the possible merger 
with Microsoft will bring them back to the top of the online business and search engine 
market. 
 The growth investing strategy is a lot more risky than the income investing 
strategy.  However, the potential of expanding and drastic rise in stock price make the 
growth strategy very tempting for risk takers.  
7.2 Companies Chosen and Reasons 
 
NOKIA (NOK): 
 Nokia is the world leading cell phone company with a long and interesting history.  
The company was first founded in 1865 by Fredrik Idestam.  Interestingly, Nokia first 
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established itself as a paper mill in southwestern Finland.  From 1865 to 1967, Nokia 
became a major industrial force.  With the merger of Nokia, a cable company and a 
rubber firm, the company found its path to electronics.  In 1981, the mobile era started, 
and Nokia made its first digital telephone switch in 1982. The Nokia mobile revolution 
started as former president Jorma Ollila took over the cooperation in 1992.  In 1998, 
Nokia became the world leader in mobile phones.  
 From the history of Nokia, it can be said that it is a very strong force in the stock 
market.  In the end of year 2007, the stock price of Nokia peaked at around $40.00.  
However, with the stock market crash in 2008 and the rise of iPhones and G1, the price 
of Nokia has gone way down and finally hit a low of $8.47 in March 2009.  With the 
current price of shares at around $15, I believe that Nokia still has plenty of room to grow 
in the Market.  Additionally, with the launch of the smart phone (Nokia N97), Nokia still 
has a chance to turn itself into a leader again.  
Table 7.2: Stock Information - Nokia 
NOKIA (NOK)  
Market Cap (Billion) 59.674 
Volume (Million) 11.45 
52 week high 18.87 
52 week low 8.47 
Current Price 15.7 
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APPLE (AAPL):  
 APPLE Computer, Inc. was first founded in 1976 by Steve Jobs and Steve 
Wozniak.  Starting with only $1,300, APPLE Computer Inc. was already a computer 
company with $1 Billion annual sales in 1982.  In the 1990s, PowerBook notebooks and 
Power Macintosh were released.   
 The launch of the revolutionary 5th generation iPod nano has brought APPLE to 
another level in the MP3 market.  Even before the launch of 5th generation, iPod nano 
dominated the MP3 market. In the end of year 2007, APPLE's stock price peaked at 
around $200.  Even though the current price ($185) is fairly close to the peak price, I still 
believe that Apple has the potential to bring itself to another level and become not just a 
world leading company in the MP3 market, but also in the computer industry.  
Table 7.3: Stock Information - Apple 
APPLE (AAPL)  
Market Cap (Billion) 165.744 
Volume (Million) 21.49 
52 week high 186379 
52 week low 78.2 
Current Price 185.02 
 
Hewlett Packard (HPQ): 
 Bill Hewlett and Dave Packard founded Hewlett Packard (HP) on January 1st 
1939.  The company started with just $5,369 and 2 employees.  In 1960, HP established 
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its first manufacturing plant in Colorado.  HP entered the NYSE for the first time in 1961 
when they expanded to a company with five-thousand employees.  Today, HP is one of 
the largest computer manufacturing firms with $118.4 billion in revenue and has about 
three hundred thousand employees worldwide.  HP is also ranked #9 in the Fortune 500 
listing.  
 The reason why HP is able to keep up with DELL is that HP manufactures high 
quality laptops and computers with a reasonable price.  HP has recovered well from the 
stock market crash.  In March 2009, HP got a huge contract to sell 9.2 million units to the 
United States Marine Corp. With the ability to customize your own laptop and PC at a 
very cheap price, HP has been a very popular choice for the consumers recently.  The 
economy is starting to get better and HP is a company with strong potentials and 
management, I believe HP will thrive again in the stock market.  
Table 7.4: Stock Information - HP 
HP (HPQ)  
Market Cap (Billion) 108.357 
Volume (Million) 3.13 
52 week high 46.72 
52 week low 25.39 
Current Price 45.5 
 
DELL (DELL): 
 With $1000 as startup capital, Michael Dell registered Dell Computer Corp. in 
1984.  Dell was the first in the industry to sell custom-built computers directly to 
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customer.  In the late 1990s, Dell had expanded its market worldwide.  Today, Dell is one 
of the largest companies in the United States, employing over 65,000 people and earning 
a revenue of $61.1 billion in 2009.  
 Dell's revenue and net income hit a low in the second quarter of 2009.  However, 
it is showing an upward trend in the third quarter.  As may be seen in all of the other 
stocks, the current price is very close to the 52-week high.  Unlike HP’s quick recovery 
from the stock market crash, Dell is recovering slowly.  Dell's peak price in the last three 
years is $31/share.  With the current price of $16.62, there is still plenty of room to grow, 
given the fact that dell is the leading laptop and computer manufacturer in the US.   
Table 7.5: Stock Information - Dell 
Dell (DELL)  
Market Cap (Billion) 32.052 
Volume (Million) 4.75 
52 week high 17.26 
52 week low 7.84 
Current Price 16.62 
 
Google (GOOG): 
 Google has grown into a comprehensive internet advertising business from an 
online search company.  The company’s revenue increased from $440 million to $21.8 
billion in just 6 years.  The corporation was report to have a 31% year-on-year growth in 
2009.  Google has finally surpassed Yahoo and was rated as the most visited website in 
May 2008 and January 2009.  
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 Google recovered very quickly from the stock market crash. the net income and 
net margin in Q1 of 2009 is comparable to that of Q3 2008 (before the stock market 
crash). With its high percentage of year on year growth, I believe Google is not just a 
stable company but also a stock posessing a very high potential to have another 
breakthrough in the stock market. 
 Google's highest stock price in recent year was $690 on October 2007.  With the 
current price at $475 and the reported growth rate, I believe investing in Google is the 
correct choice. 
Table 7.6: Stock Information - Google 
GOOGLE (GOOG)  
Market Cap (Billion) 114.166 
Volume (k) 569.2 
52 week high 476.8 
52 week low 247.3 
Current Price 475.31 
 
Yahoo (YHOO): 
 Yahoo is a global internet service company that provides services such as email, 
search, media streaming, and downloads.  Yahoo was the most visited website before 
Google took over the crown in January 2009.  86.5% of Yahoo's revenue is made up by 
their online advertising business.  Yahoo used to have the monopoly in the online 
advertising business; however, the power has shifted since 2004, when Google made 
amazing progress in the market. Even though Yahoo is no longer the market leader in 
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online advertising, I believe that the potential merger between Microsoft and Yahoo 
could bring them back to the top again.  
 After being hit hard last year in the stock market, Yahoo is recovering very slowly 
compared to other technology giants in the market.  Yahoo's peak stock price was $30 
back in September of 2007.  It has shown a downward trend since then.  With the low 
current price, there is a very good possibility that I will be able to make profit by 
investing in Yahoo. 
Table 7.7: Stock Information - Yahoo 
YAHOO (YHOO)  
Market Cap (Billion) 21.85 
Volume (Million) 21.09 
52 week high 17.68 
52 week low 8.94 
Current Price 16.04 
 
NIKE (NKE): 
 Nike is the world's largest athletic footwear manufacturer. The revenue of Nike in 
2008 totaled $18.6 billion.  The popularity of Nike’s products has made them one of the 
most global companies in the world.  34% of its total revenue came from the US, and an 
additional 30% came from the EMEA in year 2008.  The economic recession in 2008 hit 
Nike and other shoe manufacturers hard. Nike's revenue only grew 3%, and the net 
income dropped 21% in 2009. However, in Q2 of 2009, Nike's net income and net 
margin has increased from Q1.  
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 I am investing in Nike because it is the largest and the most popular footwear 
company in the world.  The economy is recovering and will only get better in the near 
future.  The demand for shoes will rise again once the economy has recovered. Nike's 
stock price peaked at $69 in the beginning of 2008.  With the current price at $54 per 
share, I believe Nike is a profitable stock in which to invest. 
Table 7.8: Stock Information - Nike 
NIKE (NKE)  
Market Cap (Billion) 21.341 
Volume (Million) 1.03 
52 week high 67.02 
52 week low 38.24 
Current Price 54.21 
 
Amazon (AMZN): 
 Amazon was founded in 1995 by Jeff Bezos.  It started off as an online bookstore, 
however, it has expanded to an online superstore that sells products from more than 40 
categories.  Amazon is the world's largest e-commerce company with revenues growing 
29.1% from 2007 to 2008.  Amazon offers low prices on high quality products with 
shipping promotions.  
 The stock price for Amazon peaked at $94 in the end of year 2007.  Even though 
the current price is very close to the peak price, Amazon has shown a very stable 
performance in the stock market in the last four months with its stock price varying from 
$87 to $91.  Amazon purchases are tax free in most of the states in the US.  Under this 
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economic situation, everyone wants to save on unnecessary costs, and consumers expect 
high-quality products at lower costs.  I believe Amazon has done a good job and will 
continue its strong performance in the stock market in the future. 
Table 7.9: Stock Information - Amazon 
Amazon (AMZN)  
Market Cap (Billion) 38.983 
Volume (Million) 6.77 
52 week high 94.40 
52 week low 34.68 
Current Price 90.28 
 
7.3 Weekly Simulation Reports 
7.3.1 Journal for Week of Sept. 21 – Sept. 27, 2009 
09/21/09 
Starting with $500,000, I bought 400 shares of Google at $497.59/share.  About 40% of 
my cash was invested in Google because I believe that it is a company with huge 
potential.  I also bought 500 shares of Yahoo, Nike and Apple.  These are my second 
largest investments.  I Bought 300 shares of HP and 100 shares of Dell and Nokia.  200 
shares of Amazon was also bought.  $135,000 cash remained in my portfolio after the 
first day. This cash will be used to invest further in Google.  
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Table 7.10: Stock Trading Summary (09/21/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/
Proceeds 
Profit/Loss Total Cash 
Total Profit 
9/21 GOOG Buy 497.59 400  588 300,944 588 
9/21 YHOO Buy 17.09 500  -115 292,379 -115 
9/21 AMZN Buy 90.37 200  676 274,285 676 
9/21 NOK Buy 15.77 100  -10 272,688 -10 
9/21 NKE Buy 58.32 500  25 243,508 25 
9/21 DELL Buy 15.99 100  -26.06 241,889 -26.06 
9/21 HPQ Buy 46.36 300  195 227,961 195 
9/21 AAPL Buy 184.13 500  175 135,876 175 
         
        1,507.94 
 
09/22/09 
No trade was made today, as I am still observing the performance of the stocks I invested 
in. 
09/23/09 
No trade was made today as I am still observing the performance of the stocks I invested 
in.  The stock market has been performing well recently.  
09/24/09 
The stock market didn't do very well today. All of my stocks went down. Therefore, I 
sold all of my Amazon and HP stocks.  I made roughly $400 from those two companies.  
Apple's stock price went down drastically, so I bought an additional 800 shares.  At the 
end of the day, Apple turned out to be the only company that I actually made a profit 
from.  
90 
 
Table 7.11: Stock-Trading Summary (09/24/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/
Proceeds 
Profit/Loss Total Cash 
Total Profit 
9/24 GOOG     21,295.25 -328 
9/24 YHOO     21,295.25 -100 
9/24 AMZN Sell 91.42 200   21,295.25 
9/24 NOK     21,295.25 -69 
9/24 NKE     21,295.25 -175 
9/24 DELL     21,295.25 -22.06 
9/24 HPQ Sell 46.69 300   21,295.25 
9/24 AAPL Buy 183.39 800   21,295.25 189.8 
         
        -504.26 
 
7.3.2 Journal for Week of Sept. 29 – Oct. 2, 2009 
09/29/09 
No Trades were made today.  All of my stocks are not doing well and are still recovering 
from the stock market hit last Friday.  
09/30/09 
Nike had a 10% growth today, very interesting trend of observe. Nike and Apple both 
had significant increase in their stock prices. A daily gain of $5,000 was obtained from 
just Nike and Apple.  Google, however, has not been performing as well as expected as 
the stock price dropped from the initially purchased $497.59 down to $495.85.  It is 
important to note that Google did recover from the drastic drop from last Friday, 
increasing the stock price from 492.48 to 495.85. 
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Table 7.12: Stock-Trading Summary (09/30/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/
Proceeds 
Profit/Loss Total Cash 
Total Profit 
9/30 GOOG  495.85   21,295.25 -696 
9/30 YHOO  17.81   21,295.25 360 
9/30 AMZN     21,295.25 
9/30 NOK  14.62   21,295.25 -115 
9/30 NKE  64.7   21,295.25 3,090.00 
9/30 DELL  15.26   21,295.25 -73.06 
9/30 HPQ     21,295.25 
9/30 AAPL  185.35   21,295.25 2,178.80 
        
        4,744.74 
 
10/02/09 
I have sold all of the Nike Stock at $62.2.  The purchased stock price was at $58.92 
which has about $3.3 increase over the past 2 weeks.  This transaction allowed an overall 
gain of $1,850.  I bought 109 shares of Google using the rest of the cash since Google's 
stock price went down by $8 in the past two weeks.  
Table 7.13: Stock-Trading Summary (10/02/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/
Proceeds 
Profit/Loss Total Cash 
Total Profit 
10/2 GOOG Buy 484.58 109   0.00 -5,835.11 
10/2 YHOO     0.00 -125 
10/2 AMZN     0.00 
10/2 NOK     0 -183.00 
10/2 NKE Sell 64.7 500   0 
10/2 DELL     0.00 -95.06 
10/2 HPQ     0.00 
10/2 AAPL     0.00 1,593.80 
        
        -4,644.37 
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7.3.3 Journal for Week of Oct. 5 – Oct. 9, 2009 
10/07/09 
I sold 1,300 shares of Apple today at $189.97 to earn $246,941.01 in cash.  The shares 
were bought at $183.70.  Therefore, this transaction has brought $8,021 of profit.  I sold 
Google at $517.54. A net profit of $10,950 was earned through investing in 509 shares of 
Google in the past two weeks.  
Table 7.14: Stock-Trading Summary (10/07/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/
Proceeds 
Profit/Loss Total Cash 
Total Profit 
10/7 GOOG Sell 517.54 509  8,021 510,428 10,941.53 
10/7 YHOO    510,428 200 
10/7 AMZN    510,428 
10/7 NOK    510,428 -139 
10/7 NKE    510,428 
10/7 DELL    510,428 -63.06 
10/7 HPQ    510,428 
10/7 AAPL Sell 189.97 1300  10,950 510,428 
        
        10,939.47 
 
10/08/09 
I bought 10,000 shares of Nvidia because the stock price has been declining for the past 2 
weeks.  
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Table 7.15: Stock-Trading Summary (10/08/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/
Proceeds 
Profit/Loss Total Cash 
Total Profit 
10/8 GOOG     371,148.04 
10/8 YHOO     371,148.04 245 
10/8 AMZN     371,148.04 
10/8 NOK     371,148.04 -137 
10/8 NKE     371,148.04 
10/8 DELL     371,148.04 -17.06 
10/8 HPQ     371,148.04 
10/8 AAPL     371,148.04 
10/8 NVDA Buy 13.93 10,000  800 371,148.04 800 
        890.94 
 
10/09/09 
I bought 72,935 shares of Sprint-Nextel because the stock price has been declining for the 
past 2 weeks.  With the new launch of HTC Hero next week, I believe Sprint-Nextel's 
stock price will increase. 
Table 7.16: Stock-Trading Summary (10/09/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/
Proceeds 
Profit/Loss Total Cash 
Total Profit 
10/9 GOOG     110,028.04 
10/9 YHOO     110,028.04 -110 
10/9 AMZN     110,028.04 
10/9 NOK     110,028.04 -108 
10/9 NKE     110,028.04 
10/9 DELL     110,028.04 -18.06 
10/9 HPQ     110,028.04 
10/9 AAPL     110,028.04 
10/9 NVDA      110,028.04 2,600 
10/9 S Buy 3.58 72,935  7.29 110,028.04 7.29 
        2,371.23 
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Figure 7.1: Monthly performance of APPLE (SEP-OCT) 
 
Figure 7.2: Monthly performance of Google (SEP-OCT) 
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Figure 7.3: Monthly performance of Sprint (SEP-OCT) 
 
Figure 7.4: Monthly performance of Nvidia (SEP-OCT) 
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7.3.4 Journal for Week of Oct. 26 – Oct. 30, 2009 
10/30/09 
No trades were made today.  The downward trend of Nvidia and Sprint have lasted for 
more than three weeks.  From Figure 7.3, it is clear that the value of Sprint shares has 
dropped significantly. The stock price per share for sprint back in August was $5.  I 
invested most of my cash into Sprint mainly because it dropped down to $4/share in 
September, and I expected the stock’s poor performance to stop.  Better performance was 
expected from Sprint because of the launch of their new smart phones and the availability 
of more cell phone plan selections.  However, Sprint's stock price per share continued to 
drop and eventually reached $2.95/share by the end of this week.  The poor performance 
of Sprint is mainly due to its $478 million net loss in the third quarter.  The loss of 
545,000 wireless subscribers was the key.  Verizon and AT&T (both are rivals with 
Sprint) have gained more wireless subscribers in the third quarter.  The Chief Executive 
Officer, Dan Hesse, assumed that the higher sign-up rate in the third quarter was a 
positive sign and would bring profit the Sprint eventually.  However, the poor 
performance continued into October.  The numerous launches of different smart phones 
was the key impact factors in the decline of Sprint's stock price. Sprint had to subsidize 
all of their smart phones to attract new customers. The launch of the Palm Pre seemed 
very helpful; however, Sprint still ended up losing revenue due to the huge amount of 
subsidies it had to put into sales of the Palm Pre.  Therefore, several stock analysts have 
suggested Sprint to just focus on the customers it has instead of trying to attract new 
customers by launching even more smart phones.  From the reported numbers, I believe 
selling all of my Sprint stocks would be a wise decision.  Moving on to Verizon or AT&T 
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might be better investment because it will take a long time for Sprint to recover from its 
loss in the third quarter. 
Nvidia's drop occurred due to the overall poor performance by the NASDAQ composite 
index.  The technology sectors have been doing well since March, and this short period 
decline is just a bit of a breather because of the uncertainty around the Christmas sell-
through. Keeping Nvidia stocks might be a wise decision because the holiday season is 
coming and the tech sectors have been getting boosts from gains in shares of Dell Inc., 
HP, and EMC Corp.  
Table 7.17: Stock-Trading Summary (10/30/2009) 
Date Symbol Buy/Sell Price Shares Net 
Cost/ 
Proceeds 
Profit/Loss Total Cash 
Total Profit 
10/30 GOOG     110,028.04 
10/30 YHOO     110,028.04 -507.5 
10/30 AMZN     110,028.04 
10/30 NOK     110,028.04 -261 
10/30 NKE     110,028.04 
10/30 DELL     110,028.04 -107.06 
10/30 HPQ     110,028.04 
10/30 AAPL     110,028.04 
10/30 NVDA      110,028.04 -13,517.00 
10/30 S      110,028.04 -37,189.56 
        -51,582.12 
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7.3.5 Journal for Week of Nov. 2 – Nov. 6, 2009 
Table 7.18: Stock-Trading Summary (11/02/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/ 
Proceeds 
Profit/Loss Total Cash 
Total Profit 
11/2 S Sell 2.82 72935 205,656.71 -55,430 315684.75 -55,430 
11/2 WDC Buy 33.91 5162   140,621.34 
 
From last week's report and research about Sprint, I have decided to sell all of my Sprint 
stocks even though I lost $55,430 by investing in Sprint.  With the extra cash, I bought 
5,000 shares of Western Digital (WDC).  By the end of this week, the stock price of 
WDC went up to $36.44 per share.  I have made $13,059.86 in profit by just investing in 
WDC.  Therefore, once the market opens on Monday, I will be trading away all 5,000 
shares of WDC because I think it has already hit its peak at $36.44.  
Western Digital has been doing well because of its successful launch of the WD TV.  
Also, it has posted a Q1 profit increase in October 22nd.  Net income of $288 million was 
up 36% from $211 million from last year.  In addition, the increasing demand of laptops 
and desktops has allowed WDC to sell more of its hard drive products.  John Coyne, 
president and CEO, said demand is being driven primarily by the "growing social media 
phenomenon.” 
nVidia shares are performing a lot better than last week.  The final price/share was 
$13.16.  The loss was reduced to $7,500 compared to $13,517 from last week.  This 
showed that the report I found last week gave a valid prediction.  I expect nVidia to keep 
rising as it is close to the holiday season and the shopping for electronics will hopefully 
help nVidia Corp.    
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7.3.6 Journal for Week of Nov. 9 – Nov. 13, 2009 
$13,059.86 profit was made from last week by investing in Western Digital. Therefore, 
the first thing I did on Monday was sell all of the WDC stocks.  With the extra cash I had 
after selling WDC, I have decided to invest in HP (Helmerich & Payne Inc.).  HP did 
well early in the week, accumulating about $3,000 in profit. However, it did not do so 
well later in the week and I ended up experiencing a loss of $4,740.  
HP is a Tulsa based energy exploration and production company.  HP was bought 
because I confused it with HPQ (the actual computer company I was going to invest in).  
However, as mentioned before, HP turned out to be a satisfactory investment overall.  
HPQ has been outstanding on the other hand.  The stock price stood at $49.91/share by 
the end of the week.  Compare to the $46.69, it is a very drastic increase.  
The loss from investing in nVidia continued to reduce, and the loss was eventually 
decreased to $3,500 by the end of the week. In the middle of the week, the stock price 
almost came back to $13.92, the purchase price.  However, it went back down and ended 
at $13.56 per share.  
From the performance of nVidia and Western Digital, it could be concluded that the 
technology sectors are recovering and starting to rise in price.  A similar trend can be 
observed in the previously invested Google and HPQ. 
Table 7.19: Stock-Trading Summary (11/09/2009) 
Date Symbol Buy/Sell Price Shares Net Cost/ 
Proceeds 
Profit/Loss Total Cash 
Total Profit 
11/9 HP Buy 38.65 6000 231,919.99  98,642.96 
11/9 WDC Sell 36.80 5162 189,941.61 13,059.86 330,562.95 13,059.86 
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Chapter 8: Comparison of Cumulative Results and Discussion 
8.1 Diversified Portfolio Utilizing Fundamental Analysis 
The initial stock purchases and subsequent trades I have made have been based on 
fundamental analysis.  Fundamental analysis strategies rely on purchasing and selling 
stocks based on their intrinsic value, not on their perceived value.  I started the simulation 
purchasing a large number of stocks in the financial sector; in particular, I purchased 
mostly bank shares.  I thought that the intrinsic value of Bank of America and the Royal 
Bank of Canada was higher than the market value. 
For the 10 years previous, Bank of America shares had not been sold for less.  
Additionally, after their acquisitions of Merill Lynch and Wachovia Financial, I believed 
that Bank of America was a wise purchase based on fundamental analysis.  However, the 
results of my trading show that relying solely on fundamental analysis is not wise.  In a 
turbulent market, stocks change value more based on reactions to short-term economic 
reports and emotions than on the intrinsic value of the shares.  As a result, I had to sell all 
of my shares in Bank of America after the market value of the stock started to plummet. 
Likewise, my initial investment in the Royal Bank of Canada was based on my perceived 
intrinsic value of the company.  As the company had posted an increase in their net 
margin from -0.6% to 16% in the most recent quarter, I decided to invest.  However, as 
investor’s woes and fears of a quick recovery worsened, the value of the Royal Bank of 
Canada’s stocks declined, and I was forced to sell them and my Bank of America stocks. 
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Additionally, Baidu.com shares changed value almost at a whim.  Many investors 
disagreed about the intrinsic value of the company, unable to establish a trading target.  
And as such, the prices fluctuated widely, even falling more than 11% in one day 
(10/27/09).  Shares have since reclaimed much of this loss, but the stock still remains 
volatile, even with a P/E ratio of more than twice Google’s (NYSE: GOOG).  Baidu.com 
is another example of a company whose value is largely based on the emotions and 
feelings of investors who do not follow fundamental analysis. 
Though Activision Blizzard did not seem to be traded based on the intrinsic value of the 
company’s worth, the short-term qualitative analysis conducted by most investors helped 
my portfolio in the short time I invested in the company.  Those who had evaluated the 
company using fundamental analysis would have known that the company was to make a 
large profit upon the release of Call of Duty: Modern Warfare 2; however, qualitative 
analysts, only upon hearing the news of the record sales, quickly purchased shares.  
Likewise, when the stock price rose quickly, many who had recently invested sold their 
stocks.  This may have been a good short-term strategy for many; however, a more long-
term fundamental analysis would recommend holding onto the stocks through the holiday 
season, as many more copies are likely to be sold.  Thus, using fundamental analysis, it is 
easier to predict the long-term increase or decrease in a company’s worth, allowing one 
to purchase shares before economic news like quarterly reports are released and 
potentially increasing profits. 
Of all of the companies presented thus far, SEI Investments Company epitomizes the 
qualitative analysis technique that most investors have adopted since the stock market 
crashed.  Qualitative analysts look at the subjective qualities and not the intrinsic qualities 
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of a company.  Though SEI Investments posted Q3 profits that beat expectations by 2 
cents per share, share values plummeted 12.5%.  Additionally as a sign of the company’s 
good health, the corporation’s net margin has been increasing since Q4 2004.  
Fundamentally, the company looks to be a good investment, but qualitative investors, 
likely weary of the rapid economic recovery, have driven the price of SEI Investments 
down. 
However, some companies did seem to be more immune to short-term economic news 
than other.  In particular, TD Ameritrade stocks appear to be traded mostly on the 
intrinsic value of the company and not on the temporal fears and delights of investors.  In 
the past three months (08/20/09 – 11/20/09), TD Ameritrade Holding’s stocks have 
increased in value 12.60%.  This augmentation is likely due to increased trading due to 
market volatility.  When stocks are traded in high volume, brokerage firms are expected 
to make a large profit, allowing them to be somewhat independent of short-term market 
woes.  Thus, for one who wishes to employ fundamental analysis as a trading strategy, it 
seems that investment in a brokerage firm, like TD Ameritrade, is an excellent choice. 
Like TD Ameritrade, other companies seem to be ideal candidates to employ 
fundamental analysis trading strategies; Raytheon Co. seems to be valued based on its 
intrinsic worth.  Raytheon shares have seen a large increase in value since the start of 
November (11.19%).  Through the recession, the company’s revenue and net margin has 
remained relatively unchanged at 5.3B and 8%, respectively.  This has indicated to 
investors that the company is relatively immune to the recession.  After plummeting in 
value in March of 2009, share prices have regained significant ground to hover around 
their pre-March values.  This indicated that, with the exception of March trading, the 
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stock is being traded with respect to its intrinsic value.  Thus, it seems that defense 
contractors are relatively immune to short-term problems in the economy and can be 
traded with respect to their fundamental value. 
Investment in the stock market is a risky endeavor and is usually only profitable by 
investing large quantities of money in an attempt to negate the cost of trade commissions.  
Significant research, both into entire industries and into individual corporations, must be 
carried out if the investor is to make educated, strategic decisions.  Fundamental analysis, 
though not employed by all investors, can be used to help determine which stocks to buy 
and to sell based on the company’s intrinsic worth.  Though some companies are more 
susceptible to market fluctuations and should not be traded with respect to fundamental 
analysis, investment in some industries, such as defense contracting, can be guided by the 
principles of fundamental analysis.   
8.2 Investing in the Life Sciences using Company History and Projected Growth 
I began this simulation by searching for companies with historically good 
reputations.  Moreover, I chose companies with high interest coverage ratios, which 
reflected stable companies able to pay their debts.  Additionally, I chose companies with 
a history of growth or a potential for growth.  These companies either had a penchant for 
consuming other companies, or had products that seemed indispensible for modern health.  
Genzyme and Illumina were two companies on my list that had a history of 
acquiring other companies, an event that caused a leap in stock prices and profit for 
investors.  Genzyme has acquired eight companies in recent history, while Illumina 
bought-out CyVerta in 2005 and Solexa in 2007.  
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Gilead Sciences and Celgene seemed to have great potential for growth due to 
their product lines. Gilead sciences in particular seemed promising, due to its effective 
line of HIV drugs. It was something of a gamble, but I knew from research that steps 
were being taken to extend humanitarian aid to AIDS victims that were previously not on 
the market, and that a big shift in this direction could be explosively profitable. 
I also targeted four companies based on their production of the right product at the 
right time: companies that produced the swine flu vaccine. These companies were 
AstraZeneca (AZN) Novartis (NVS), GlaxoSmithKline (GSK), and Sanafi-aventis (SNY). 
As flu season set in and the media fueled hysteria over the disease ran its course, I 
predicted that these stocks would increase in value.   
 Unfortunately, most of my investments turned out to be unprofitable, mostly due 
to problems with FDA approval, company facilities, or low projections made by the 
companies themselves.  This simulation has taught me that any pharmaceutical company 
is a high-risk investment. 
Illumina 
 I sold all of my stock in Illumina before the simulation had ended. After an 
excellent start when it was common to see the stock rise by 1-3% in a day, Illumina’s 
value suddenly plummeted on the 22nd of October. This occurred because their reported 
guidance for next year dropped from $720 million down to 651 million, which executives 
blamed on slow sales. What was once my star stock had to be sold at a steep loss, costing 
me $21,000 total. In the future, it would be far better to anticipate such announcements 
and sell the stock before the announcement was made. One could gamble on next year’s 
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projection being higher than expected, but this experience has taught me to guard oneself 
against loss. 
Gilead Sciences 
 Gilead Sciences is another company of which I sold all stock in before the end of 
the simulation. Despite reporting excellent third quarter results in late October, the stock 
plummeted shortly afterward. This was probably due to lower than expected sales of the 
drug, Truvada. The stock recovered most of its value shortly after, but the sharp decline 
of  this day left a bad taste in my mouth. It seemed that Gilead’s reputation was unformed 
in investor’s minds, and it was consistently a source of negative income in my portfolio. I 
sold it at a loss of $6,000 dollars. It turned out that this was the right thing to do. By the 
end of the simulation, Gilead had dropped another 4%. 
Celgene 
Celgene, like Gilead Sciences, experienced a sharp drop in late October despite good 
third quarter reports (which even predicted that next yer’s profits would be 18% higher 
than this year’s). However, it quickly recovered the lost value. Overall, the stock retained 
its value and did not incur much loss or profit. 
Swine Flu Producers 
AstraZeneca stocks were largely static during the simulation, with the final value 
being slightly higher than the initial investment. Analysts from all corners were hailing 
this stock as a great potential, but a recent lawsuit by users of the psychiatric drug, 
Seqorel, may destroy that potential. Seqorel users claim that the drug causes diabetes, and 
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recently a federal judge ruled that many of the cases should be held in their local courts, 
probably to the disadvantage of the company. If the simulation were still running I would 
unhesitatingly sell this stock for what little profit it now has.  Sanofi Aventis was also 
largely static.  
Novartis and Glaxo-Smith-Kline were the only two very successful investments 
that I made during this simulation. Novartis increased in value by almost twenty percent, 
and GlaxoSmithKline by almost eight.  Each was propelled upward by promising new 
drugs and FDA approvals, as well as their outputs of the swine flu vaccine. Each 
experienced shortages, but this was expected due to an impossible demand for the 
valuable product.  Neither company reported the technical difficulties experienced by 
Genzyme. 
Genzyme 
 Analysts have called the Genzyme stock a “train wreck.”  Until recently, the 
company has shown strong growth, with an average of 22% growth each year from 2003 
to 2008.  Then, a series of related misfortunes sent the stock on a downward spiral, with 
my investment in tow. 
It started when the FDA announced a three-month-delay on its verdict for a 
Genzyme drug, Myozyme.  This made investors nervous, and when the results finally 
came out, Myozyme was banned.  The drug was not safe for use in humans. After this 
occurred, contamination problems in one of the company’s manufacturing plants forced it 
to shut down, causing shortages.  This made the company look like an unreliable provider, 
unable to meet its self-set deadlines.  Further problems cropped up last week when the 
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FDA warned that about 1% of the vials coming out of the company contained bits of 
steel, rubber, and fiber.  The Genzyme drugs that have been flagged as contaminated are 
still circulating, because they treat diseases that lack other types of therapy.  Finally, the 
last domino fell when Genzyme gave up on a new kidney drug, claiming that it was less 
effective than another drug they had in circulation.  The company’s value gradually 
dropped by 20%  while I had it in my portfolio. Due to this, my final losses were close to 
$30,000, a 6% decrease in buying power. 
Genzyme more than any other company, has taught me that investing in the life 
sciences, especially pharmaceutical companies, is unsound.  The research and 
development of new drugs is totally inaccessible to the investor, so products may be 
approved or disapproved by the FDA with no way of accurately predicting the result.  
There is also the vulnerability of these companies to contamination, and the inflammatory 
nature (due to its intimate relationship with patients’ lives) of any mistake made by the 
company.  Any foul-up and the company laboratories will be sensational news.  It would 
be better to pursue opportunities in other sectors of the marketplace, such as agriculture, 
which may be more predictable due to weather patterns that are accessible by everyone. 
8.3 Video Game Industry Stocks with Historically Strong Market Performance 
I had originally picked my stocks based on their historically strong performance.  
By sticking with companies within the video game industry, I hoped I could make a good 
judgment about which of the major companies in both software and hardware 
development performed the strongest over the time that I spent during the simulation. 
Of the three hardware companies, Microsoft, Sony, and Nintendo, I made the 
most profit off of Microsoft shares.  By the end of the simulation, my sales had netted me 
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a profit of $8,164.71 from the company, whereas Sony only yielded me a profit of 
$488.92.  I did not make any profit by investing in Nintendo.  Nintendo was usually in 
the red in my portfolio, and when it was in the black, I did not think it was enough to do 
anything about it. 
Overall Microsoft’s stock rose by $4.52 from start to finish.  I sold it while it was 
about $1 above start and $3 above start, which were the causes for my large profits.  
Sony’s stock rose by only $.02, but I managed to sell it while it was about $1 above 
starting point; thus, I was able to make a profit.  Nintendo’s stock actually went down 
$0.89. 
Of the four Software companies (Activision Blizzard, Konami, Electronic Arts, 
and Take-Two), I made the most profit from Electronic Arts, which netted me a profit of 
$6,471.40 by the end of the simulation.  Take-Two made me $4,390.40, and Activision-
Blizzard only made me $385.76.  Konami was the only company that lost me money in 
the end. It was only about $85.80, but every other company I invested in either did not 
make me any profits or made me a profit. 
Overall, Activision-Blizzard’s stock rose only $0.06 from start to finish, but I 
managed to sell it while it was up by about $1.00, making me a profit. Konami’s stock 
went up by $.11, but I bought more stocks at a price lower than what I had originally 
bought at and sold stocks while I was still in the negative, so I ended up losing money 
overall.  Electronic Art’s stock dropped by $0.39 over the course of the simulation, but I 
was able to sell it while it was up by $1, and then again up by $2.50, resulting in a 
sizeable profit-margin. Take-Two’s stock rose by $0.61; however, I sold off all of my 
shares while it had gone up by $.89, so I made a profit on from the investment. 
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PepsiCo was the only non-video game stock that I purchased, but it only made me 
a profit of $604.01.  It rose by $2.42 by the end of the simulation.  I sold it while it was 
down by about $1, and again while it was up by $2.50. This gave me a smaller profit than 
I otherwise would have, but still a profit. 
In terms of my own portfolio, Microsoft and Electronic Arts gave me the biggest 
gains, which does not surprise me.  Microsoft is an economic powerhouse and has done 
very well over the years.  It is one of the most well known companies and has some of the 
highest sales in the video game industry. Electronic Arts is another economic powerhouse, 
and is one of the best-known video game publishing companies in the world.  Both 
companies aggressively seek out other successful, smaller companies and acquire them 
through various means to expand themselves and make their companies more profitable. 
It does not surprise me that they performed the best out of all of the companies I invested 
in. 
Sony, Activision-Blizzard, and Take-Two also did very well overall, and although 
they did not make me as much as Microsoft or Electronic Arts, they still made me a 
decent profit.  I had expected this, so I was pleased.  Konami performed very poorly 
overall; however, the company is very small and does not have a large presence on the 
stock market so I was not very surprised by this. 
The only company that really surprised me was Nintendo, which ended up being 
the only company that went below the price I bought it at by the end of the simulation.  
Share values rose a few times during the simulation, but never by very much. Nintendo is 
a huge name in video game consoles, and the Nintendo Wii and DS are ahead of 
competitors in their respective markets.  I had expected them to do better than they did, 
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but overall the choice was not a complete failure.  By the end, I still made a profit by 
investing in Nintendo. 
PepsiCo also did a bit worse than I had expected, although I only bought their 
shares to diversify my portfolio.  I had not expected them to make me a significant profit, 
but they are a leading company in the field of soft drinks and snack foods, so I expected 
them to do a little better than they did.  
I learned a lot about successful stock trading strategies over the course of the 
simulation, and although my portfolio’s value was only slightly above its starting point at 
the end, I managed to make a profit of about $17,000 overall.  I am quite pleased with 
this, especially since it was only an eight-week period. 
8.4 Investing in Technology and Shoe Manufacturing Sectors using the Income and 
Growth Strategies 
The companies I had selected at the beginning of the simulation were all mature and 
consistent stock performers.  Initially, I invested a lot of my cash in two major companies, 
APPLE and GOOGLE.  They did not perform as well as I expected in the first few days.  
However, the stock price/share drastically increased for both stocks, especially GOOGLE.  
Google has been doing very well recently, reaching its 52-week high at $572/share in the 
past week.  Even though a lot of profit was made by investing in Google, I should not 
have sold it at $519/share.  The difference of $53/share says a lot about Google's 
potential and innovation in the technology sector.  Therefore, Google should be regarded 
as one of the fastest growing/recovering companies since the stock market crash last year.  
From this, I have learned that a lot of patient investigations are needed when investing in 
such big company like Google, because the profit made in the long run could be very 
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significant.  One of the reasons for its top-performance, was Google’s innovation of the 
Google Wave, which is the search engine giant's real-time collaboration platform. It lets 
users send e-mails and instant messages from one plaette.  Wave was only created back in 
May, but the user population rose sharply to 100,000 users in September 30th, 2009.  
Within a short amount of time, Google was able to understand its customer’s desires and 
made the necessary adjustments to Google Wave.  From this case, it can be easily said 
that in order to succeed in the technology sector, one must do what Google is doing, 
understanding customer's needs and wants.  This is why Google has over-taken Yahoo in 
a short period of time.  I had also invested in Yahoo, but its stock price dropped by 10% 
within the eight-week simulation period. 
Apple's launch of the new generation iPods was very successful, which could be seen 
from its stock price increase in the past eight weeks.  Now standing at $200/share, Apple 
was being traded at $184/share eight weeks ago.  That is almost a 10% increase in stock 
price.  In this new generations of iPods, it was well reflected that Apple has done a lot of 
research in customer's needs and wants, fixing all the problems with the previous 
generation iPods.  Understanding customer desires is why Google and Apple are the two 
companies that are still standing-tall during this economic recession.  
By comparing Apple and Sprint, it is apparent that customers in the technology sectors do 
not want new models every time, instead, they are looking for the companies to fix the 
problems they've addressed.  Apple has done that well, while Sprint was a complete 
failure. Its stock price is currently at $3.76/share, having even dropped below $3/share 
during the course of the simulation. Similar comparison could be found in Dell and 
Hewlett Packard.  The two companies are rivals in the computer industries, yet, HP is 
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doing well at $50.04/share, whereas Dell is not doing as well at $14.29/share. Since the 
simulation started, HP has experienced a 10% overall stock price increase, whereas Dell 
has been doing poorly with 10% overall stock price decrease.  The key difference 
between the two giants is that HP had offered different styles and designs on their laptop 
computers where as Dell did not.  HP understands that each customer is looking for the 
"special" laptop for himself or herself.  Therefore, HP offered a wide range of 
customizations that could be done to the laptop from color to the overall design.  
In this recession, companies like Apple, Google and HP are doing a lot better when 
compared to their rivals.  These three companies are similar in that they did a very good 
job performing market research; they addressed customer’s problem as quickly as they 
could and they have established their brands very well, raising the brand-awareness for 
consumers. 
Chapter 9: Conclusion 
 The members in the simulation team each chose their favorite companies and 
investing strategies to create his/her own portfolio.  The project included four separate 
portfolios managed by each of the individual members during an eight-week simulation 
process.  Microsoft Excel was used to keep a record of all the transactions made, while 
Investopedia was chosen as a stock simulator.  An allowance of $500,000 was given to 
each group member to invest.  Each portfolio had its own focus in either the 
pharmaceutical, gaming or technology sectors. 
 During the eight-week simulation, the U.S. economy was still recovering from the 
crash a year ago. Some sectors were recovering quickly whereas the others wereas others 
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were recovering more slowly, and this had some negative impacts on some of our 
portfolios.  Only one out of the four portfolios made a profit.  The performance of the 
portfolios seemed to be based on the specialization or focus that each member chose at 
the beginning of the simulation.  The one portfolio that chose to specialize in gaming 
industries turned a profit, showing that the gaming industries were recovering faster than 
the pharmaceutical and technology sectors.  These results were typical given the short 
time period. 
 In conclusion, this simulation provided a basic introduction to the investment 
world.  We have accomplished our goals through the research in various investment 
vehicles and trading strategies.  Our understanding of the stock market and its potential to 
increase the value of an investor's portfolio over time was also improved after the 
simulation and research experience. 
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Appendix 
List of Stock Exchanges around the World: 
South America 
  Argentina 
 Buenos Aires Stock Exchange (MERVAL)  
 Bolivia 
 Bolsa Boliviana de Valores (BBV) web site  
 Brazil 
 BM&F Bovespa (São Paulo Stock Exchange)  
 Rio de Janeiro Stock Exchange (BVRJ)  
 Maringá Mercantile and Futures Exchange  
 BOVMESB (Minas, Brasília and Espírito Santo Stock Exchange)  
 Chile 
 Santiago Stock Exchange 
 Santiago Electronic Stock Exchange 
 Valparaíso Stock Exchange (BOVALPO) 
 Colombia 
 Bolsa de Valores de Colombia (BVC)  
 Costa Rica 
 Bolsa Nacional de Valores de Costa Rica (BNV) 
 Ecuador 
 Bolsa de Valores de Guayaquil (BVG)  
 Bolsa de Valores de Quito (BVQ)  
 El Salvador 
 Bolsa de Valores de El Salvador (BVES)  
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 Guatemala 
 Bolsa Nacional de Valores (BNV)  
 Guyana 
 Guyana Stock Exchange  
 Honduras 
 Bolsa Centroamericana de Valores (BCV)  
 Bolsa de Valores de Honduras (BHV)  
 Nicaragua 
 Bolsa de Valores dre Nicaragua (BVDN)  
 Panama 
 Bolsa de Valores de Panama (BVP)  
 Paraguay 
 Bolsa de Valores y Productos de Asunción (BVPASA)  
 Peru 
 Bolsa de Valores de Lima (BVL)  
 Uruguay 
 Bolsa de Valores de Montevideo  
 Bolsa Electronica de Valores de Uruguay BEVSA  
 Venezuela 
 Bolsa de Valores de Caracas (Caracas Stock Exchange) (BVC)  
Africa 
  Botswana 
 Botswana Stock Exchange (BSE)  
 Cameroon 
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 Douala Stock Exchange (DSX)  
 Cape Verde 
 Bolsa de Valores de Cabo Verde (BVC)  
 Egypt 
 Cairo & Alexandria Stock Exchange (CASE)  
 Ghana 
 Ghana Stock Exchange (GSE)  
 Kenya 
 Nairobi Stock Exchange (NSE)  
 Malawi 
 Malawi Stock Exchange (MSE)  
 Mauritius 
 The Stock Exchange of Mauritius (SEM)  
 Morocco 
 Casablanca Stock Exchange  
 Mozambique 
 Maputo Stock Exchange  
 Namibia 
 Namibian Stock Exchange (NSX)  
 Nigeria stock exchange forlagos 
 Nigerian Stock Exchange  
 Abuja Stock Exchange  
 South Africa 
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 JSE Securities Exchange / Johannesburg Stock Exchange (JSE)  
 JSE Alternative Exchange (ALTX)  
 The South African Futures Exchange (SAFEX)  
 Bond Exchange of South Africa (BESA)  
 Sudan 
 Khartoum Stock Exchange (KSE)  
 Swaziland 
 Swaziland Stock Exchange (SSX)  
 Tanzania 
 Dar-es-Salaam Stock Exchange (DSE)  
 Tunisia 
 Bourse de Tunis (BVMT)  
 Uganda 
 Uganda Securities Exchange (USE)  
 West Africa 
 Bourse Regionale des Valeurs Mobilieres (BRVM)  
 Zambia 
 Lusaka Stock Exchange (LuSE)  
 Zimbabwe 
 Zimbabwe Stock Exchange (ZSE)  
Asia 
  Afghanistan 
 Kabul International Stock Exchange  
 Bahrain 
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 Bahrain Stock Exchange  
 Bangladesh 
 Chittagong Stock Exchange  
 Dhaka Stock Exchange  
 People's Republic of China 
 Shanghai Stock Exchange  
 Shenzhen Stock Exchange  
 Hong Kong 
 Hong Kong Exchanges and Clearing (HKEx)  
 India 
 Ahmedabad Stock Exchange  
 Bangalore Stock Exchange  
 Bhubaneshwar Stock Exchange  
 Bombay Stock Exchange (BSE)  
 Calcutta Stock Exchange  
 Cochin Stock Exchange  
 Coimbatore Stock Exchange  
 Delhi Stock Exchange Association  
 Gawahati Stock Exchange  
 Hyderabad Stock Exchange (HSE)  
 Inter-connected Stock Exchange of India  
 Jaipur Stock Exchange  
 Ludhiana Stock Exchange Association  
 Madhya Pradesh Stock Exchange  
 Madras Stock Exchange (MSE)  
 Mangalore Stock Exchange  
 National Stock Exchange of India (NSE)  
 OTC Exchange of India  
 Pune Stock Exchange  
 Uttar Pradesh Stock Association  
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 Vadodara Stock Exchange  
 Meerut Stock Exchange  
 Indonesia 
 Indonesia Stock Exchange (IDX)  
 Jakarta Futures Exchange (JFX)  
 Iran 
 Tehran Stock Exchange (TSE)  
 Iraq 
 Iraq Stock Exchange (ISX)  
 Israel 
 Tel-Aviv Stock Exchange (TASE)  
 Japan 
 Fukuoka Stock Exchange  
 JASDAQ Securities Exchange  
 Nagoya Stock Exchange  
 Osaka Securities Exchange  
 Sapporo Stock Exchange  
 Tokyo Stock Exchange  
 Jordan 
 Amman Stock Exchange  
 Kazakhstan 
 Kazakhstan Stock Exchange (KASE)  
 Kuwait 
 Kuwait Stock Exchange  
 Kyrgyzstan 
 Kyrgyz Stock Exchange  
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 Lebanon 
 Beirut Stock Exchange  
 Malaysia 
 Bursa Malaysia  
 Kuala Lumpur Commodity Exchange  
 Bursa Derivatives  
 MESDAQ  
 FTSE Bursa Malaysia Index  
 Maldives 
 Maldives Stock Exchange  
 Mongolia 
 Mongolian Stock Exchange  
 Nepal 
 Nepal Stock Exchange  
 Oman 
 Muscat Securities Market  
 Pakistan 
 Islamabad Stock Exchange (ISE)  
 Karachi Stock Exchange (KSE)  
 Lahore Stock Exchange (LSE)  
 Palestine 
 Palestine Securities Exchange (PSE)  
 Philippines 
 Philippine Stock Exchange (PSE)  
 Philippine Dealing Exchange (PDEx)  
 Saudi Arabia 
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 Saudi Arabia Electronic Securities Information System, precursor to Tadawul  
 Tadawul  
 Singapore 
 Singapore Exchange (SGX)  
 Singapore Commodity Exchange (SICOM)  
 Sri Lanka 
 Colombo Stock Exchange  
 South Korea 
 Korea Exchange  
 Taiwan 
 Taiwan Stock Exchange  
 Thailand 
 Stock Exchange of Thailand (SET)  
 Agricultural Futures Exchange of Thailand (AFET)  
 Thailand Futures Exchange (TFEX)  
 Market for Alternative Investment (MAI)  
 United Arab Emirates 
 Abu Dhabi Securities Market  
 Dubai Financial Market  
 Dubai International Financial Exchange  
 Uzbekistan 
 Tashkent Stock Exchange  
 Vietnam 
 Ho Chi Minh Stock Exchange (HOSE)  
 Hanoi Securities Trading Center (HASTC)  
Oceania 
 Australia 
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 Australia Pacific Exchange (APX)  
 Australian Securities Exchange (ASX)  
 Bendigo Stock Exchange (BSX)  
 National Stock Exchange of Australia (NSX) formerly Newcastle Stock Exchange  
 Sydney Futures Exchange (SFE)  
 Fiji 
 South Pacific Stock Exchange (SPSE), formerly the Suva Stock Exchange  
 New Zealand 
 New Zealand Exchange Limited (NZX)  
 Papua New Guinea 
 Port Moresby Stock Exchange Limited (POMSoX)  
Europe 
  Pan-European 
 Euronext  
 OMX Exchanges  
 Armenia 
 Armenian Stock Exchange (Armex)  
 Austria 
 Wiener Börse  
 Azerbaijan 
 Baku Stock Exchange  
 Belgium 
 Euronext Brussels  
 Bosnia and Herzegovina 
 Sarajevo Stock Exchange (SASE)  
 Banja Luka Stock Exchange (BLSE)  
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 Bulgaria 
 Bulgarian Stock Exchange  
 Channel Islands 
 Channel Islands Stock Exchange  
 Croatia 
 Zagreb Stock Exchange (ZSE)  
 Cyprus 
 Cyprus Stock Exchange (CSE)  
 Czech Republic 
 Prague Stock Exchange (PSE)  
 Denmark 
 Copenhagen Stock Exchange (KFX), one of the OMX Exchanges  
 Estonia 
 Tallinn Stock Exchange, one of the OMX Exchanges  
 Faroe Islands 
 Faroese Securities Market, in cooperation with Iceland Stock Exchange (VMF)  
 Finland 
 Helsinki Stock Exchange, one of the OMX Exchanges (HEX, Helsingin Pörssi / 
Helsingfors Börs)  
 France 
 Euronext Paris (CAC 40)  
 Georgia 
 Georgian Stock Exchange (GSX)  
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 Germany 
 Berliner Börse  
 Börse Hamburg  
 Börse Hannover  
 Börse München  
 Börse Stuttgart  
 Börse Düsseldorf  
 Eurex (Frankfurt-based; (owned by Deutsche Börse and SWX)  
 Frankfurt Stock Exchange (owned by Deutsche Börse; Index: DAX)  
 Gibraltar 
 Gibraltar Stock Exchange (GibEX)  
 Greece 
 Athens Stock Exchange (General)  
 Hungary 
 Budapest Stock Exchange (BSE) In association with Wiener Börse  
 Iceland 
 Iceland Stock Exchange (Kauphöll Íslands)  
 Ireland 
 Irish Stock Exchange (ISE or ISEQ)  
 Irish Enterprise Exchange (IEX)  
 Italy 
 Borsa Italiana  
 Latvia 
 Riga Stock Exchange, one of the OMX Exchanges  
 Lithuania 
 Vilnius Stock Exchange, one of the OMX Exchanges  
 Luxembourg 
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 Luxembourg Stock Exchange  
 Macedonia 
 Macedonian Stock Exchange  
 Malta 
 Malta Stock Exchange  
 Moldova 
 Moldavie Stock Exchange  
 Montenegro 
 Montenegro Stock Exchange  
 NEX Stock Exchange  
 Netherlands 
 Euronext Amsterdam (AEX index)  
 Norway 
 Oslo Stock Exchange  
 Poland 
 Warsaw Stock Exchange (WSE, GPW - Giełda Papierów Wartościowych w 
Warszawie)  
 NewConnect  
 Portugal 
 Euronext Lisbon (PSI-20)  
 OPEX  
 Romania 
 Bucharest Stock Exchange (Bursa de Valori Bucureşti or BVB) (indices BET, 
BET-C, BET-FI and ROTX)  
 SIBEX (formerly known as Sibiu Monetary Financial and Commodities 
Exchange)  
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 RASDAQ, merged with Bucharest Stock Exchange in December 2005, becoming 
one of its market sections.  
 Russia 
 Moscow Interbank Currency Exchange (MICEX)  
 Moscow Stock Exchange(MSE)  
 RTS Stock Exchange  
 Saint Petersburg Stock Exchange (SPBEX)  
 Serbia 
 Belgrade Stock Exchange (BELEX)  
 Slovakia 
 Bratislava Stock Exchange (BSSE)  
 Slovenia 
 Ljubljana Stock Exchange (LJSE)  
 Spain 
 Bolsas y Mercados Españoles  
o Bolsa de Madrid  
o Borsa de Barcelona  
o Bolsa de Valencia  
o Bolsa de Bilbao  
 Sweden 
 Nordic Growth Market – specializes in exotic options like turbo warrants  
 Stockholm Stock Exchange, one of the OMX Exchanges  
 Switzerland 
 SWX Swiss Exchange  
 Bern eXchange (BX)  
 Turkey 
 Istanbul Stock Exchange (ISE)  
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 Ukraine 
 PFTS Ukraine Stock Exchange  
 United Kingdom 
 London Stock Exchange (FTSE 100 Index)  
 Plus Markets  
 Markit BOAT  
 Project Turquoise  
North America 
  Bahamas 
 Bahamas Securities Exchange  
 Barbados 
 Barbados Stock Exchange (BSE)  
 Bermuda 
 Bermuda Stock Exchange (BSX)  
 Canada 
 CNQ  
 Nasdaq Canada  
 TSX Group  
o Toronto Stock Exchange  
o TSX Venture Exchange  
 Winnipeg Commodity Exchange  
 Montreal Exchange  
 Cayman Islands 
 Cayman Islands Stock Exchange (CSX)  
  Costa Rica 
 Bolsa Nacional de Valores de Costa Rica  
 Cuba 
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 Havana Stock Exchange closed in September 1960  
 Dominican Republic 
 Bolsa de Valores de la República Dominicana  
 Eastern Caribbean 
 Eastern Caribbean Securities Exchange (ECSE)  
 El Salvador 
 Bolsa de Valores de El Salvador  
 Guatemala 
 Bolsa de Valores de Guatemala  
 Honduras 
 Bolsa Centroamericana de Valores  
 Bolsa Honduras de Valores  
 Jamaica 
 Jamaica Stock Exchange  
 Mexico 
 Bolsa Mexicana de Valores (BMV)  
 Nicaragua 
 Bolsa de Valores de Nicaragua  
 Panama 
 Bolsa de Valores de Panama  
 Trinidad and Tobago 
 Trinidad and Tobago Stock Exchange  
 United States of America 
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 American Stock Exchange (AMEX)  
 Boston Stock Exchange (BSE)  
o Boston Equities Exchange (BEX)  
o Boston Options Exchange (BOX)  
 Chicago Board Options Exchange (CBOE)  
 Chicago Board of Trade (CBOT) - Owned and operated by CME Group Inc.  
 Chicago Mercantile Exchange (CME) - Owned and operated by CME Group 
Inc.  
 Chicago Stock Exchange (CHX)  
 International Securities Exchange (ISE)  
o ISE Options Exchange  
o ISE Stock Exchange  
 Miami Stock Exchange (MS4X) 
 NASDAQ Stock Market, The - Owned and operated by NASDAQ OMX 
Group, Inc. (formerly The Nasdaq Stock Market, Inc.).  
o NASDAQ Global Select Market  
o NASDAQ Global Market (formerly NASDAQ National Market)  
o NASDAQ Capital Market (formerly NASDAQ Small Cap Market)  
 National Stock Exchange (NSX)  
 New York Stock Exchange (NYSE) - Owned and operated by NYSE 
Euronext.  
o NYSE Arca (formerly Pacific Exchange)  
 Philadelphia Stock Exchange (PHLX)  
 
